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 ABSTRACT  
DEFINING THE MECHANISM BY WHICH SYNTHETIC POLYMER SURFACES 
SUPPORT HUMAN PLURIPOTENT STEM CELL SELF-RENEWAL
by 
Xu Qian 
Chair: Paul H. Krebsbach 
 
Human pluripotent stem cells (hPSCs), which include embryonic stem cells (hESCs) and 
induced pluripotent stem cells (hiPSCs), have become a promising resource for regenerative 
medicine and research into early development because these cells are able to indefinitely self-
renew and are capable of differentiation into specialized cell types of all three germ layers and 
trophoectoderm. However, a major limitation for successful therapeutic application of hPSCs 
and their derivatives is the potential xenogeneic contamination and instability of current culture 
conditions. Synthetic polymers, such as poly[2-(methacryloyloxy) ethyl dimethyl-(3-sulfopropyl) 
ammonium hydroxide] (PMEDSAH), offer multiple advantages over mouse embryonic 
fibroblasts (MEFs) and Matrigel for hPSC culture. The main purpose of this dissertation is to 
define the mechanisms by which hPSCs are propagated on synthetic polymers. 
By physical modifications of PMEDSAH, we found that modifying substrate thickness changed 
the physical properties, and thus altered pluripotent stem cell behavior. Our data suggest that the 
!
!
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105 nm thick atom transfer radical polymerization (ATRP) PMEDSAH possesses the optimal gel 
architecture for hPSC expansion with its intermediate thickness, hydrophilicity, surface charge, 
and a moderate degree of inter-chain association. Our findings demonstrate the importance of 
polymer physical properties in hPSC expansion. The 105 nm thick ATRP PMEDSAH and 
similar modifications may be used to obtain scalable populations of clinical-grade hPSCs for 
regenerative medicine.  
Although a specific group of transcription factors, such as OCT4, SOX2 and NANOG, are 
known to play critical roles in hPSC pluripotency and reprogramming, other factors and the key 
signaling pathways regulating these important properties are not completely understood. In this 
dissertation, we also investigated the role of the PSC marker Developmental Pluripotency 
Associated 5 (DPPA5) in hPSCs. Our data demonstrate higher expression of DPPA5 in hPSCs 
under PMEDSAH and other feeder-free conditions, compared to MEFs. DPPA5 stabilizes 
protein levels and enhances the function of NANOG. Finally, DPPA5 increases the hiPSC-
reprogramming efficiency. These results provide new molecular insight into the function of the 
DPPA5 in hPSCs. Our findings extend our understanding of the mechanism by which 
PMEDSAH and other feeder-free conditions support hPSC self-renewal, and offers 
improvements to current protocols in hPSC maintenance and reprogramming. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Problem Statement 
Human pluripotent stem cells (hPSCs) include embryonic stem cells (hESCs) derived from the 
inner cell mass of blastocyst-stage embryos and induced pluripotent stem cells (hiPSCs) 
generated by reprogramming somatic cells by the overexpression of key transcription factors [1-
3]. The capacity for indefinite self-renewal and differentiation into specialized cell types of all 
three germ layers and trophoectoderm makes hPSCs a promising resource for regenerative 
medicine, tissue engineering, disease modeling, drug screening and understanding early events in 
human development. However, a key prerequisite for successful therapeutic application of 
hPSCs and their derivatives is the ability to develop strategies for large-scale production of 
clinical-grade cells [4-6] .   
Currently, the large-scale production of clinical-grade hPSCs is limited by potential xenogeneic 
contamination and instability of current culture conditions [1, 7, 8]. To overcome these 
limitations, synthetic polymers [9-17] have been developed for propagation of hESCs because of 
the following features: completely defined chemical composition, stability during storage, 
reproducibly synthesized and cost-effectiveness [18]. Among the synthetic substrates, 
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poly[2-(methacryloyloxy) ethyl dimethyl-(3-sulfopropyl) ammonium hydroxide] (PMEDSAH), a 
fully defined synthetic polymer coating has demonstrated effective capacity to support hPSC 
self-renewal and expansion in long-term culture [12, 19, 20]. Currently, PMEDSAH is the only 
truly synthetic substrate that contains no biologic components such as proteins, peptides or 
sugars. A complete understanding of the mechanism by which PMEDSAH supports hPSC self-
renewal is a key to unlock its great potential for large-scale propagation of hPSCs.  
Recent studies demonstrated that physical properties such as hydrophilicity [12], surface 
roughness [21] and stiffness [22, 23] impact the capability of synthetic substrates to support 
hESC growth [18]. However, the mechanisms by which PMEDSAH and other synthetic 
substrates maintain self-renewal of hPSCs are not yet clearly understood. Moreover, although a 
specific group of transcription factors, such as OCT4, SOX2 and NANOG, are known to play 
important roles in hPSC pluripotency and reprogramming [24-27], other factors and the key 
signaling pathways regulating these properties are not clearly understood. Appropriate culture 
conditions are critical to maintain the pluripotency of hPSCs in vitro. From a molecular 
biological perspective, these culture methods should be able to support the transcriptional and 
signaling networks maintaining pluripotency. Compared to the most widely used hPSC culture 
condition, mouse embryonic fibroblasts (MEFs), PMEDSAH and other feeder-free conditions 
may have different transcriptional and signaling networks that support hPSC self-renewal. 
Currently, very few publications focus on the mechanism and impact of in vitro conditions on 
pluripotency regulatory networks. In this thesis, we investigated the mechanism by which 
PMEDSAH support hPSC self-renewal from two different perspectives: 1) physical mechanism - 
the physical properties and the extent to which these physical properties of PMEDSAH impact 
its capacity to support hPSC self-renewal; 2) molecular mechanism - the molecules and signaling 
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pathways that play critical roles in supporting hPSC self-renewal on PMEDSAH and other 
feeder-free substrates. 
1.2 General Hypothesis  
The physical properties of coating surfaces and specific pluripotency-related factors play 
important roles in hPSC self-renewal on synthetic polymers. 
1.3 Specific Aims 
Two specific aims are proposed to test the hypothesis. 
Specific Aim 1. To determine the effects of physical properties on the ability of synthetic 
polymer coatings to support hPSC self-renewal  
By increasing the reaction time of atom transfer radical polymerization (ATRP), we expect to 
modify the gel architecture of PMEDSAH without changing its chemical structure. Polymer 
characterization will be performed to determine what physical properties are modified. We aim 
to identify cell adhesion, proliferation and self-renewal by determining the number and area of 
undifferentiated colonies, total cell number, stem cell marker expression and pluripotency of the 
hPSCs cultured on grafted or ATRP PMEDSAH. By accomplishing this specific aim, we expect 
to identify which physical properties of synthetic polymer coatings and the extent to which these 
physical properties influence hPSC maintenance and expansion. 
Specific Aim 2 To determine which molecules and signaling pathways are essential in 
supporting hPSC self-renewal on synthetic polymers 
Using microarray analysis, we expected to identify the genes that have significantly different 
expression levels between hPSCs cultured on PMEDSAH and MEFs. Quantitative RT-PCR will 
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be used to validate the results by microarray. The genes related to pluripotency, cell attachment 
or/and proliferation, and that consistently expressed differently between different hPSC lines on 
PMEDSAH and MEFs will serve as our targets for further investigation. These studies include 
their expression on other feeder-free substrates and their impact on hPSC self-renewal and 
reprogramming. By accomplishing this specific aim, we expect to find novel signaling networks 
regulating hPSC pluripotency on synthetic polymers, and likely discover new factors that support 
hPSC self-renewal. 
1.4 Summary of Thesis Contents 
Chapter 2 is a review of literature based on our published manuscript in Journal of Dental 
Research  (Critical Reviews in Oral Biology and Medicine) [28]. This chapter summarizes recent 
advances in hPSC maintenance and methods to induce hiPSCs and controlled lineage 
differentiation by regulating cell-signaling pathways, altering gene expression and manipulating 
the extracellular environment that stem cells experience.   
Chapter 3 is written based on our published manuscript in Biomaterials [29]. This chapter details 
the experiments we conducted to address Specific Aim 1: to determine the effects of physical 
properties on the ability of synthetic polymer coatings to support hPSC self-renewal. hPSCs were 
cultured on grafted and ATRP PMEDSAH. Cell expansion and self-renewal were assayed by 
determining the number of undifferentiated colonies and total cells, cell stemness and 
pluripotency. We found that the105 nm thick ATRP PMEDSAH possesses the optimal gel 
architecture for hPSC expansion with its intermediate thickness, hydrophilicity, surface charge, 
and a moderate degree of inter-chain association. Our findings suggest that physical properties 
influence the ability of PMEDSAH to support hPSC self-renewal. Modifying the physical 
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properties through increasing the film thickness of PMEDSAH may advance our current 
techniques for hPSC maintenance and expansion. 
Chapter 4 is written based on our manuscript that is under revision for Stem Cells [30]. This 
chapter describes our work to address Specific Aim 2: to determine which molecules and 
signaling pathways are essential for supporting hPSC self-renewal on synthetic polymers. 
Microarray and quantitative RT-PCR demonstrated that compared to MEFs, hPSCs cultured on 
PMEDSAH and other feeder-free substrates had higher gene expression of Developmental 
Pluripotency Associated 5 (DPPA5), a PSC marker with unknown function in hPSCs, while the 
expression of other pluripotency-related factors such as OCT4, SOX2 and KLF4 had no 
significant differences. We then focused on the function of DPPA5 in hPSCs and found that the 
extracellular matrix deposited by irradiated MEFs, as well as secreted soluble factors, inhibited 
the expression of DPPA5, while its expression and function were permissive under feeder-free 
conditions. DPPA5 plays an important role in supporting hPSC self-renewal and reprogramming 
by stabilizing protein levels and enhancing the function of NANOG, a key transcription factor 
for hPSC pluripotency. Our findings that in vitro conditions impact DPPA5 expression and the 
pluripotency regulatory networks advance our understanding of the mechanism by which 
synthetic polymers and other feeder-free substrates support hPSC self-renewal. We also provide 
new molecular insight into the function of the pluripotent stem cell marker DPPA5 in hPSCs. 
Chapter 5 is a summary of the thesis results and a prospectus for future directions of the work.  
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CHAPTER 2 
REVIEW OF LITERATURE 
 
2.1 Progress in Human Pluripotent Stem Cell Culture: from Dependence on 
Feeder Cells to Culture on Synthetic Matrices 
Human pluripotent stem cells (hPSCs) include embryonic stem cells (hESCs) derived from the 
inner cell mass of blastocysts and induced pluripotent stem cells (hiPSCs) generated by the 
overexpression of key transcription factors in somatic cells [1-3]. The derivation and culture of 
human embryonic stem cell (hESC) lines was originally described using the same procedure 
described for mouse ESCs (mESCs). These methods included gamma irradiated mouse 
embryonic fibroblasts (MEFs) as feeder cells and culture medium supplemented with fetal 
bovine serum (FBS) [1]. However, since the nature of mouse and human ESCs is not identical 
[4], the culture conditions to support their growth have proved to be different as well. Due to its 
undefined conditions and variability, the above-mentioned medium was replaced with knockout 
serum replacer and fibroblast growth factor 2 (FGF2) for hPSC culture. As feeder cells, MEFs 
provide attachment sites for hPSCs and secrete multiple, but largely uncharacterized factors that 
induce signaling networks to regulate hPSC fate. However, the interactions among hPSCs and 
murine feeder cells highlight xenogeneic contamination as a major concern and thus limit the use 
of MEFs in therapeutic applications for humans. 
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Micro-organisms and non-human bioactive molecules are two general sources of xenogeneic 
contamination of hPSCs when co-cultured on MEFs. Viruses may be transferred from feeder 
cells to contaminate the cell derivatives of hPSCs. Compared to other micro-organisms, viral 
contamination is difficult to detect and address during cell culture. Viruses such as lymphocytic 
choriomeningitis virus (LCMV), first isolated from mouse colonies, have been reported to infect 
cell lines [5]. Certainly, the possible presence of viruses in MEFs and serum would increase the 
risk for culturing clinical-grade hPSCs. Furthermore, non-human bioactive molecules such as 
Neu5Gc have been identified on the surface of hESCs when co-cultured with MEFs [6]. These 
bioactive molecules may induce an immune response in recipients of transplanted hPSC-
derivatives. In addition, gamma-irradiation, which is used to inhibit MEF proliferation, induces 
apoptosis in feeder cells and leads to instability of the culture microenvironment [7], impacting 
both mechanistically driven research and clinical application of hPSCs. 
To avoid the risks of animal contamination from MEFs, human feeder cells have been used for 
hPSC culture [8]. Multiple types of human cells—including fibroblasts derived from fetal 
muscle, fetal skin, adult fallopian tubal epithelium, placenta, uterine endometrium, foreskin and 
mesenchymal cells—have been validated for their capability to support hPSCs self-renewal. 
Among human feeder cells, fibroblast-like cells derived from hPSCs offer a potential autogenic 
system to support self-renewal of hPSCs. In addition to the diversity of human feeder cell lines, 
other innovations have been introduced, such as the use of FGF2 secreting human fibroblasts as 
feeder cells. This strategy reduced the need for exogenous supplementation of FGF2 to the 
culture medium [9]. Another innovation in hPSC culture is the use of an indirect co-culture 
system that is based on a microporous polymer membrane that allows real-time conditioning of 
the culture medium by human fibroblasts, while maintaining complete separation between hPSCs 
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and feeder cells [10]. Nevertheless, the risk of contamination by human pathogens remains a 
concern when using human feeder cells. Therefore, comprehensive screening and tests are 
required before feeder cells can be used in the culture of hPSCs intended for clinical applications.  
To reduce the instability and potential contamination brought on by feeder cells, feeder-free 
culture systems for hPSCs have been developed. MatrigelTM, the trade name for an extracellular 
matrix (ECM) extracted from Engelbreth-Holm-Swarm (EHS) mouse sarcomas, was the first 
example of a feeder-free substrate for hPSC culture [11]. To determine which components of 
MatrigelTM, as well as other ECM molecules, may support hPSCs, a variety of specific ECM 
proteins have been examined. It has been reported that human recombinant (hr) laminin isoforms 
-111, -332 and 511, and hr vitronectin support the growth of undifferentiated hPSCs [12, 13]. 
Human recombinant E-cadherin, another cell-cell interaction mediator, has also been reported to 
support hPSC self-renewal [14]. These purified proteins are examples of defined and 
xenogeneic-free substrates being used for hPSC culture. Because these proteins are generated as 
recombinant factors, they may not be subjected to lot-to-lot variations observed in MatrigelTM 
extracts and other potential contaminations. However, human recombinant proteins are labor 
intensive and costly to produce, which complicates their large-scale use. Therefore, the 
development of fully synthetic substrates for hPSC culture represents a new milestone in hPSC 
culture by overcoming many of the obstacles presented by biological substrates. Synthetic 
substrates have the following superiorities: they are defined, reproducible and stable, show 
minimal lot-to-lot variability, demonstrate better scalability, are cost-effective and easily 
prepared [15]. All these advantages make synthetic substrates promising for large-scale 
expansion of clinical-grade hPSCs and their derivatives for therapeutic use.  
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Peptide-based systems with surface arrays of self-assembled monolayers have been used to 
identify peptide surfaces that support hPSC self-renewal. Arrays of laminin-derived peptides, 
heparin-binding peptides and high-affinity cyclic RGD peptides have all been shown to support 
hPSC culture [16-18]. The composition of surface array elements, specifically density and 
sequence of peptides, has been reported to impact the ability of substrates to support 
hPSC growth [16].  
Numerous polymer-based substrates have been developed by different methodologies. For 
example, poly[2-(methacryloyloxy) ethyl dimethyl-(3-sulfopropyl) ammonium hydroxide] 
(PMEDSAH) is a fully defined synthetic polymer substrate developed through a surface-initiated 
graft polymerization technique [19]. Hit 9 and the aminopropylmethacrylamide, APMAAm, are 
both fabricated by photopolymerization [20, 21]. Both the semi-interpenetrating polymer 
hydrogel poly(N-isopropylacrylamide-co-acrylic acid) and the poly(methyl vinyl ether-alt-maleic 
anhydride) (PMVE-alt-MA), an anhydride containing polymer substrate, are generated by radical 
polymerization [22, 23]. In addition, combinatorial approaches for polymer substrates have been 
implemented by using polymers as base substrates that are modified with biomolecules such as 
vitronectin and amino-containing peptides [20, 24]. All these substrates have demonstrated 
effective capacity to support hPSC growth.  
Synthetic substrates for sustained hPSC culture are generally more stable and reproducible when 
compared to the first generation culture systems. Clearly, understanding the molecular 
mechanisms that maintain self-renewal of hPSC will be critical for the modification and 
improvement of the currently available technologies. Although not yet completely understood, 
the following physico-chemical properties may impact the capability of substrates to support 
hPSC growth: hydrophilicity, surface roughness, stiffness [15] as well as the application of cell 
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adhesion elements such as heparin-binding peptides [17] and laminin-derived peptides [16]. 
Additionally, the compatibility of synthetic substrates with common sterilization techniques such 
as ultraviolet (UV) light radiation is another characteristic that may impact the effectiveness of 
substrate preparations. For example, substrates with biological components such as proteins and 
peptides are usually incompatible with common sterilization methods because biological 
components may undergo denaturation or degradation during the sterilization process. From this 
point of view, the pure polymer-based synthetic substrates may be superior to other substrates for 
hPSC culture.  
2.2 Culture Medium, Supplements and Cell Signaling 
In addition to feeder cells and feeder-free substrates, another key component of an effective 
hPSC culture system is the culture medium. Accompanied by the evolution of other components 
of the culture system, the development of new culture medium has undergone the following 
evolution: from medium containing serum to serum-free medium, and from feeder cell-
conditioned medium to chemically-defined and xenogeneic-free medium. As mentioned above, 
the culture of hPSCs was originally performed with fetal bovine serum (FBS) to supplement the 
culture medium [1] and later was replaced by knockout serum replacer and fibroblast growth 
factor 2 (FGF2) [25]. Human serum has also been used to replace animal-derived serum for the 
purpose of pursuing xenogeneic-free conditions. However, it has been reported that human 
serum may only support hPSC for up to 10 passages [8]. At the early stages of feeder-free culture 
system development, MEF conditioned medium (CM) was commonly used [11]. However, to 
avoid drawbacks such as multiple unknown and variable factors that CM contains, chemically 
defined media have been developed to work with xenogeneic-free substrates. This advancement 
not only paves the way for future large-scale production of clinical-grade hPSCs, but also 
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provides an ideal system for studying the molecular mechanisms of hPSC self-renewal [15]. For 
example, mTesR medium was the first xenogeneic-free and serum-free commercial medium 
developed [26], and further research has improved it into a chemically defined medium that 
contains only human proteins and 8 defined components [27]. 
A variety of biological and chemical supplements for culture medium have been reported to 
facilitate hPSC self-renewal. Many of these discoveries and applications are the result of a 
greater understanding of hPSC pluripotency, which has been translated to the development of 
better additives and conditions. Some of these factors include FGF2, insulin, TGFβ, BMP, Wnt 
and IGF-II. In feeder cell culture systems, FGF2 has been shown to support hPSC self-renewal 
by promoting the expression of IGF-II, Activin A (a member of TGFβ superfamily) and Gremlin 
(a BMP antagonist) in feeder cells [28, 29]. In feeder-free cell culture systems, FGF2 has been 
reported to support undifferentiated hPSC growth without conditioned medium at a 
concentration of 100ng/ml [30]. In other studies, dual activation of Smad3 and Erk by Activin A 
and FGF2 in serum-free and xenogeneic-free culture conditions was shown to support long-term 
maintenance of hESCs [28]. Moreover, it has been also reported that hESCs secrete a low-
molecular-mass FGF2 (18-kDa) isoform and express its receptor, FGFR1. Blocking this receptor 
with a pharmaceutical inhibitor (SU5402) results in cell differentiation, suggesting a critical role 
for autocrine FGF signaling in maintaining hPSC self-renewal [31]. In addition, studies have 
indicated that Activin A is an effective medium supplement for hPSC self-renewal because it can 
enhance the expression of transcription factors, such as OCT4, (also known as POU5F1), SOX2 
and NANOG in hESCs [28]. The observation of phosphorylation and localization of SMAD2/3 in 
the nucleus also indicates the activation of TGFβ/ Activin A / Nodal pathways in undifferentiated 
hPSCs [32]. 
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Similar to the TGFβ signaling pathway, the activation of the Wnt signaling pathway by a GSK-
3-specific inhibitor has been reported to support the self-renewal of hPSCs [33]. BMP has the 
opposite effects of TGFβ and Wnt signaling pathways on hPSC self-renewal, since its inhibition 
supports self-renewal of these cells. For example, Noggin (500ng/ml), a BMP antagonist, can 
support undifferentiated hESCs on MatrigelTM in combination with FGF2 (40ng/ml) [34]. 
However, the studies of signaling pathways regulating hPSC self-renewal are still limited and it 
remains unclear whether other signaling molecules or pathways may be involved. 
2.3 Cell Lineage Differentiation of Human Pluripotent Stem Cells 
Just as culture conditions to expand hPSC in the undifferentiated state have evolved to the point 
of using defined and xeno-free conditions, the protocols to induce in vitro cell lineage 
differentiation have been improved significantly in the past few years. This advancement is 
essential for maximizing the potential of hPSC derivatives for therapeutic use and to improve our 
understanding of the molecular mechanisms of tissue and organ development. Initial protocols to 
induce differentiation of hPSCs involved the formation of embryoid bodies (EB) in serum-
containing medium, followed by adherent culture of EBs on gelatin-coated plates. Subsequent 
outgrowth of a heterogeneous cell population can then be sorted or selected for the desired cell 
lineage. This methodology was implemented, for example, to derive mesenchymal stem cells 
from hESCs [35]. 
In contrast, by recapitulating lessons from embryonic development, controlled cell lineage 
conversion toward progenitors and fully differentiated cells has been achieved by treatment of 
monolayer cultures of hPSCs and derivatives with morphogens and chemical inhibitors in serum-
free medium. The following are a few examples of controlled differentiation into cells 
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representative of the three germ layers and trophoectoderm (Figure 2-1). The capacity of hPSCs 
to differentiate into trophoblasts has been demonstrated by treatment with several members of 
the TGFβ superfamily, such as BMP4, BMP2, BMP7 and GDF5, but not with TGFβ1 or Activin 
A [36]. Conversely, the dual inhibition of BMP and TGFβ by Noggin and SB431542, a specific 
chemical inhibitor, direct the differentiation of hPSCs towards a neuronal lineage (PAX6+ cells). 
Once this initial differentiation is directed, neural crest stem cells can be isolated by flow 
cytometry using p75 and HNK1 antibodies [37]. Further neuronal specification of PAX6+ cells 
towards motor neurons has been achieved by first promoting the caudalization of induced 
neurons with retinoic acid, followed by treatment with sonic hedgehog (SHH) to induce neuronal 
ventralization. Maturation into motor neurons is finally promoted by treatment with BNDF, 
GNDF and IGF-I [38]. 
The formation of definitive endoderm (DE) is a prerequisite for further differentiation into 
mature endoderm derivatives from anterior foregut, midgut and posterior foregut endoderm. 
Thus, to induce formation of DE, undifferentiated hPSCs are treated with Activin A [39]. To 
specify their identity towards anterior foregut endoderm (AFE) progenitor cells, Activin A-
induced DE cells are treated with dual inhibition of TGFβ and BMP signaling. AFE-induced 
cells can then be directed towards cells expressing ventral AFE markers such as NKX2.1, PAX1 
and NKX2.5 if treated with a combination of WNT3a, KGF, FGF10, BMP4 and EGF. In turn, 
ventral induced-AFE cells can give rise to cells expressing high SFTPC mRNA levels, when 
exposed to a regimen of retinoic acid, Wnt3a, FGF10 and FGF7, suggesting the derivation of 
lung cells. Treatment of ventral induced-AFE cells with either FGF8 or sonic hedgehog (SHH) 
induces the up-regulation of the parathyroid-specific marker GCM2 [40]. Derivatives from the 
posterior foregut endoderm lineages have also been induced in vitro by treatment of DE cells 
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derived from hPSCs. For example, to generate hepatic cells, Activin A-induced DE cells are 
stimulated with FGF4 and BMP2 [41], while intestinal cell differentiation requires treatment 
with FGF4 and WNT3a in three dimensional culture conditions [42]. Pancreatic cells have been 
derived by sequential treatment of DE cells with FGF10 and KAAD-cyclopamine followed by 
retinoic acid [43]. 
The derivation of multipotent mesoderm progenitors has been achieved by treatment of hPSCs 
with BMP4 and Activin A [44, 45]. Interestingly, the progression towards defined differentiation 
conditions for mesoderm progenitors includes the use of synthetic substrates functionalized with 
peptide ligands for α5β1 and α6β1 integrins instead of MatrigelTM [46]. To induce differentiation 
towards primitive streak-mesendoderm, the precursor of mesoderm, hPSCs are treated with 
Activin A, Wnt3a, FGF2 and BMP4.  Subsequently, to reduce expression of endoderm genes in 
these populations, Activin A and Wnt3a are substituted with follistatin. In turn, directed-
mesoderm cells can be induced to chondrocytes by subsequent treatment with GFD5 instead of 
BMP4 [47].  Effective cardiomyocyte differentiation of hPSCs has been achieved with temporal 
modulation of canonical Wnt signaling by treatment with Gsk3 inhibitors followed by inhibitor 
of Wnt production-4 (IWP4) supplementation. Alternatively, similar results can be obtained 
when the later chemical inhibitor is replaced by shRNA inhibition of β-catenin [48]. 
2.4 Derivation of Human Induced Pluripotent Stem Cells  
The discovery that somatic cells could be reprogrammed into iPSCs has been recognized as a 
milestone in finding the true potential of cells in disease modeling, drug screening and 
regenerative medicine. hiPSCs were first derived from adult human dermal fibroblasts by 
transducing cells with four preprogramming factors, OCT4, SOX2, LKF4 and C-MYC into the 
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cells [2]. Other combinations of reprogramming factors such as OCT4, SOX2, NANOG and Lin 
28 have also been found able to redirect human somatic cells into hiPSCs by a lentiviral delivery 
system [3]. However, the low reprogramming efficiency (~0.1%) [2, 3, 49] and the risk of 
insertional mutations by genomic integration of these reprogramming factors are the major 
challenges in the field [50].  
Alternative approaches have been applied for generating “safer” hiPSCs by avoiding vector 
sequences that may become integrated into the cell genome. Non-integrating viruses such as 
adenoviruses and Sendai viruses have been used as expression vectors in hiPSC-reprogramming. 
Compared to adenoviruses with very low hiPSC-reprogramming efficiency (0.0002%) [51], 
Sendai viruses are able to reprogram more types of somatic cells into hiPSCs with large amounts 
of protein production and significantly higher reprogramming efficiency (~1%) [52-54]. Using 
non-viral methods in hiPSC-reprogramming is another major trend to prevent genomic 
integration. For example, mRNAs of the reprogramming factors were manufactured using in 
vitro transcription (IVT) reactions and transfected into human fibroblasts to generate hiPSCs, 
resulting in high reprogramming efficiency (1.4%). However, this method is labor and cost-
intensive, and has been validated only in one somatic cell type [55]. In addition, proteins of the 
reprogramming factors were delivered into human fibroblasts by an E. Coli expression system 
for hiPSC generation. Minicircle DNA vectors containing the promoter and cDNA of the 
reprogramming factors were also transfected into human adipose stromal cells to derive hiPSC 
[56]. The major limits for using proteins and Minicircle vectors in hiPSC derivation are their 
poor reprogramming efficiency (~0.006%) and validation in few cell types. 
Besides the significant impact of reprogramming approaches including different combinations of 
reprogramming factors [3, 57, 58], the efficiency of hiPSC derivation is also related to factors 
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such as parental cell types, cell plating density and culture medium. Numerous molecules have 
been demonstrated to increase the hiPSC-reprogramming efficiency through different 
mechanisms: valproic acid and sodium butyrate inhibit histone deacetylation [59, 60]; Vitamin C 
and Rho-associated coiled coil forming protein serine/threonine kinase (ROCK) inhibitor 
promotes cell survival [61, 62]; PD0325901 blocks MEK pathway, while SB43152 inhibits 
TGFβ pathway [63]; PS48 and Oxygen (5%) promotes glycolysis [64, 65]. In addition, a recent 
study demonstrated the benefit of sequential introduction of reprogramming factors in which a 
sequential EMT-MET (epithelial-to-mesenchymal transition followed by mesenchymal-to-
epithelial transition) mechanism increased reprogramming efficiency [66]. Taking the above 
factors into consideration can optimize protocols in hiPSC-reprogramming. 
2.5 New Trends in Inducing Specific Cell Lineages 
The observation that genetic manipulation can be used to induce specific cell lineage fate is 
reinforced by the recent development of hiPSCs by overexpressing key transcription factors that 
are able to redirect the cell-fate of somatic cells [2, 3]. This has opened an exciting new avenue 
of research on directing the fate of somatic cells into specific cell types without passing through 
a pluripotent state. One early example of direct reprogramming, even before the derivation of 
iPSCs, was the generation of induced-skeletal muscle cells by overexpression of MyoD in 
fibroblasts and other somatic cells, suggesting that this transcription factor is a master regulator 
of myogenesis [67]. Subsequently, the reprogramming of fibroblasts into other specific cell types 
has been reported. Cardiac myocytes, for example, have been induced from fibroblasts after the 
overexpression of three developmental transcription factors, GATA4, MEF2C and TBX5 [68]. 
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The direct generation of proliferative neuronal precursor cells and functionally distinct neuronal 
subtypes from mouse and human fibroblasts has been described by forced expression of selected 
transcriptions factors. Neuronal precursor cells capable of self-renewal and differentiation into 
neurons, astrocytes and oligodendrocytes have been induced by reprogramming fibroblasts with 
combinations of transcription factors that include SOX2, FOXG1 and BRN2 [69] or 
BRN4/POU3f4, SOX2, KLF4, C-MYC and E47/TCF3 [70]. Interestingly, SOX2 seems to function 
as a master regulator in the neuronal stem cell fate, since its single overexpression is able to 
induce multipotent neural stem cells [71]. Conversely, overexpression of MYT1l and BRN2 in 
combination with microRNA-124 induce the generation of functional neurons that exhibit typical 
neuronal morphology, marker gene expression, generate action potentials and produce functional 
synapses between each other [72]. Induction of dopaminergic neurons has been reported by force 
expression of MASH1 (also known as ASCL1), NURR1 (also known as NR4A2) and LMX1a [73], 
while the induction into spinal motor neurons required the use of seven factors: ASCL1, BRN2, 
MYT1l, LHX3, HB9, ISL1 and NGN2 [74]. In contrast, the induction of neural crest stem cells 
(NCSC) with capacity to differentiate into multiple neural crest-derived mesenchymal and 
neuronal lineages has been achieved by the single ectopic expression of Notch1 in melanocytes 
[75]. NCSCs are precursors of melanocytes, which indicates that the later cells may already have 
NCSC-related pathways that become activated by a single master regulator. Importantly, direct 
lineage reprogramming is possible between cell types with different germ layer origins. For 
example, it has been demonstrated that terminally differentiated hepatocytes (endoderm) can be 
induced into neurons (ectoderm) using the same neuronal transcription factors (ASCL1, BRN2, 
MYT1l) that will convert fibroblasts—which may have a mesoderm-neural crest origin—into 
induced-neurons [76].   
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It has been observed that during the reprogramming of fibroblasts to iPSCs, subpopulations of 
cellular intermediates emerge that co-express genes associated with differentiated lineages.  
Those subpopulations fail to establish a pluripotent state, but have the potential to be re-directed 
into specified cell lineages with appropriated signaling inputs. In this way, fibroblasts with 
forced expression of OCT4 and treatment with FLT3 and SCF are directed into multi-lineage 
blood progenitors that give rise to granulocytic, monocytic, megakaryocytic and erythroid 
lineages with in vivo engraftment capacity [77]. Similarly, transient transduction of OCT4, SOX2, 
KLF4 and C-MYC into fibroblasts followed by treatment with FGF2, EGF and FGF4 induces 
transdifferentiation into neuronal progenitor cells [78]. In contrast, when followed by inhibition 
of the JAK-STAT pathway, cardiomyocyte formation is induced [79]. 
2.6 The Transcriptional Regulatory Network of Pluripotency 
Appropriate culture conditions and approaches are essential to support the pluripotency and self-
renewal of hPSCs. From a molecular biological perspective, this pluripotent state is maintained 
by a network of transcriptional factors and signaling pathways.  
The transcription factors OCT4, SOX2 and NANOG are known as gatekeepers of pluripotency 
in hPSCs because of their specific expression pattern and essential roles in hPSCs and early 
development [80-84]. Studies demonstrate that down-regulation of these genes in hPSCs induces 
differentiation, while overexpression of the genes support hPSC self-renewal and pluripotency. 
OCT4, SOX2 and NANOG compose the core transcriptional regulatory circuitry in hPSCs by 
co-occupying a substantial portion of their target genes, many of which encode transcription 
factors strongly associate with pluripotency and development. Interestingly, OCT4, SOX2 and 
NANOG also co-bind to the promoters of their own genes and form positive auto-regulatory 
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loops [85]. The finding of this transcriptional regulatory circuitry including auto-regulatory and 
feed-forward loops not only provides new insight into the molecular mechanism by which OCT4, 
SOX2 and NANOG support hPSC pluripotency, but also indicates the complexity of the 
pluripotency regulatory network. 
Although core transcription factors such as OCT4, SOX2 and NANOG are found to play critical 
roles in both mouse and human PSCs, the pluripotency regulatory networks contain substantial 
differences between the two species. For example, studies suggest that fibroblast growth factor 2 
(FGF2) and Activin/Nodal signaling pathways are essential for hPSC maintenance, while which 
is not required in mPSCs [28, 34, 86-90]. In addition, the protein PRDM14 has been identified as 
an effective pluripotency regulator in hPSCs but not in mPSCs because PRDM14 enhances 
OCT4 expression in hPSCs and induces differentiation when being down-regulated. These 
results were not found in mPSCs [91-93]. However, compared to mPSCs, less is known about 
the pluripotency regulatory network in hPSCs. More studies are needed to identify new 
pluripotency regulatory factors and characterize novel signaling pathways supporting hPSC self-
renewal. 
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2.7 Figures 
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Figure 2-1. Controlled cell lineage induction by manipulation of signaling pathways and 
gene expression in vitro. This illustration shows how human pluripotent stem cells (hPSC) - 
human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) - can be 
maintained in the pluripotent state or directed into specific cell lineages by manipulating key 
signaling pathways and gene expression. hESCs are derived from the inner cell mass of the 
blastocyst, while hiPSCs are induced by overexpression of pluripotent genes in somatic cells (top 
center). Similarly, overexpression of other specific genes in somatic cells can induce their 
reprogramming into different cell identities (top right). Both hPSCs can be directed into 
derivatives of the three germ layers (ectoderm, endoderm and mesoderm) and trophoectoderm by 
sequential stimulation and inhibition of signaling pathways with morphogens and chemical 
inhibitors (bottom). IGF: insulin-like growth factor, FGF: fibroblast growth factor, TGFβ: 
transforming growth factor β; BMP: bone morphogenetic protein, RA: retinoic acid, SHH: sonic 
hedge-hoc, BNDF: brain-derived neurotrophic factor, GNDF: glial-derived neurotrophic factor, 
EGF: epidermal growth factor GDF: growth differentiation factor. Credit: Xu Qian, et al. J Dent 
Res 2013;92:956-62      
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CHAPTER 3 
ENHANCEMENT OF THE PROPAGATION OF HUMAN EMBRYONIC 
STEM CELLS BY MODIFICATIONS IN THE GEL ARCHITECTURE OF 
PMEDSAH POLYMER COATINGS 
 
3.1 Abstract 
Well-defined culture conditions are essential for realizing the full potential of human embryonic 
stem cells (hESCs) in regenerative medicine where large numbers of cells are required. Synthetic 
polymers, such as poly[2-(methacryloyloxy) ethyl dimethyl-(3-sulfopropyl) ammonium 
hydroxide] (PMEDSAH), offer multiple advantages over mouse embryonic fibroblasts (MEFs) 
and MatrigelTM for hESC culture and expansion. However, there is limited understanding of the 
mechanisms by which hESCs are propagated on synthetic polymers coatings. Here, the effects of 
PMEDSAH gel architecture on hESC self-renewal were determined. By increasing the atom 
transfer radical polymerization (ATRP) reaction time, the thickness of PMEDSAH was increased 
and its internal hydrogel architecture was modified, while maintaining its overall chemical 
structure. A 105 nm thick ATRP PMEDSAH coating showed a significant increase in the 
expansion rate of hESCs. Theoretical calculations suggested that 20,000 hESCs cultured on this 
substrate could be expanded up to 4.7x109 undifferentiated cells in five weeks. In addition, 
hESCs grown on ATRP PMEDSAH coatings retained pluripotency and displayed a normal 
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karyotype after long-term culture. These data demonstrate the importance of polymer physical 
properties in hESC expansion. This and similar modifications of PMEDSAH coatings may be 
used to obtain large populations of hESCs required for many applications in regenerative 
medicine. 
3.2 Introduction 
Because of the capacity to self-renew indefinitely and to differentiate into specialized cell types 
of all three germ layers and trophoectoderm, human embryonic stem cells (hESCs) have become 
a potential source of cells for regenerative medicine, tissue engineering, disease modeling and 
drug screening. However, the successful therapeutic application of hESCs and their derivatives is 
based on the ability to develop clinically compliant strategies for large-scale bioprocessing of 
therapeutically relevant cells [1-3]. 
Currently, the large-scale expansion methods for hESCs and induced pluripotent stem cells 
(iPSCs) are limited by xenogeneic components and poorly defined culture conditions that utilize 
feeder cells and other animal-based products to support hESC self-renewal [4-6]. To overcome 
these limitations, the use of human recombinant proteins like laminin isoforms -111, -332, 511, 
vitronectin, or E-cadherin have been tested for long-term maintenance of hESCs [7-9]. These 
findings suggest a trend in the evolution of hESC culture from feeder-cell dependence and ill-
defined conditions, to feeder-free and defined microenvironments [10]. However, purification of 
human recombinant proteins is costly and significantly limits their potential for large-scale 
propagation of hESCs. Likewise, the inclusion of protein-based substrates adds a level of 
complexity to the study of the mechanisms by which a surface coating supports the pluripotency 
of hECSs.  
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Recently, synthetic substrates [11-19] have demonstrated high potential for large-scale expansion 
of hESCs because they exhibit the following effective features: completely defined chemical 
composition, stability during storage, reproducibly synthesized, cost-effectiveness, and 
compatibility with standard sterilization techniques [20]. Among these synthetic substrates is 
poly[2-(methacryloyloxy) ethyl dimethyl-(3-sulfopropyl) ammonium hydroxide] (PMEDSAH), a 
fully defined synthetic polymer coating, developed through a surface initiated graft 
polymerization technique, which has demonstrated effective capacity to support hESC self-
renewal and expansion in long-term culture [14, 21]. 
Recent evidence suggests that physico-chemical properties, such as hydrophilicity [14], surface 
roughness [22] and stiffness [23, 24] can impact the capability of synthetic substrates to support 
hESC growth [10]. However, the mechanisms by which PMEDSAH and other synthetic 
substrates maintain self-renewal of hESCs are not yet clearly understood. Therefore, we 
hypothesized that the physical properties of PMEDSAH coatings, as determined by the 
interfacial architecture of the zwitterionic surface layer, can influence the self-renewal of hESCs. 
In this study, PMEDSAH films with different thicknesses were prepared on tissue culture 
polystyrene using a combination of chemical vapor deposition polymerization [24] and atom 
transfer radical polymerization (ATRP) [25]. The impact of gel architecture on hESC self-
renewal was then tested on PMEDSAH polymer coatings over a range of thicknesses. 
3.3 Materials and Methods 
3.3.1 Synthetic Surface Preparation and Characterization  
UVO-initiated Free Radical Polymerization 
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UVO-initiated free radical polymerization was carried out in a fume hood with connections for 
argon and vacuum. A 500 mL reaction vessel was degassed by vacuum for 60 minutes. While the 
reaction vessel was being evacuated, a monomer solution consisting of 0.25 M MEDSAH 
(Sigma Aldrich) was dissolved in a mixture of deionized water and ethanol (4:1, v/v). The 
solution was degassed for 40 minutes using an argon purge. Once the reaction vessel and solvent 
were degassed, the monomer solution was transferred to a reaction vessel and heated to 68-70°C. 
While the reaction vessel was being heated, TCPS dishes (BD Biosciences) were activated by 
UV ozone treatment (Jetlight Inc.) for 40 minutes to create initiation sites on the surface.  
Samples without functionalization that consisted of poly-p-xylylene coated silicon wafers and 
gold wafers were also added to the cell culture dishes to enable thickness and contact angle 
measurement.  After activation, the dishes were transferred to a reaction vessel and the 
temperature was raised to 76-80°C. Surface-initiated polymerization occurred over a 2.5 hr time 
period under argon atmosphere at 76-80°C. Once the process was complete, TCPS plates and 
control samples were removed from the reaction vessel and were rinsed in a 1% saline (w/v) 
solution at 50 °C. 
CVD and Ellipsometry 
The initiator used for ATRP was synthesized through chemical vapor deposition (CVD) 
polymerization of 40 mg of [2.2]paracyclophane-4-methyl-2-bromoisobutyrate precursor, which 
was loaded into the sublimation zone. Sublimation occurred at 120°C, followed by pyrolysis at 
540-550°C, after which a thin film of poly[(p-xylylene-4-methyl-2-bromoisobutyrate)-co-(p-
xylylene)] was coated on the target substrates. The tissue culture polystyrene (TCPS) plates as 
well as surrogates (gold and silicon wafers) were placed on a rotating stage in the deposition 
chamber and were maintained at 15°C during CVD polymerization. Ellipsometry was performed 
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on the silicon wafers to measure thickness of the initiator coating before and after the ATRP.  
Film thickness was assessed with a multi-wavelength imaging null-ellipsometer (EP3 Nanofilm, 
Germany). Fixed values of the real (n=1.58) and imaginary (k=0) refractive index of the polymer 
coatings and the ellipsometric delta and psi were used to determine film thickness. After the 
reaction was completed, the thickness of PMEDSAH coating was calculated by subtracting the 
initial thickness from the post-reaction thickness.  
Atom Transfer Radical Polymerization 
Poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl)ammonium hydroxide] (PMEDSAH) 
(Monomer Polymer Dajac Labs, Trevose, PA) was polymerized using a ATRP procedure. 
Initiator coated substrates were prepared according to the CVD process described above. 
Initiator-coated samples and TCPS were placed in a glove bag and degassed using 3 cycles of 
vacuum-argon purge and left at room temperature under argon. A 4:1(v/v) mixture of methanol 
and water was degassed by three cycles of freeze-pump-thaw. Approximately 20% of the 
degassed solvent was transferred to a degassed flask. The monomer was then dissolved in the 
main flask and the copper/ligand mixture was dissolved in the second flask. After 10 minutes the 
catalyst mixture was added to the monomer solution and mixed thoroughly at room temperature. 
The polymerization solution was finally transferred to the glove bag and distributed among the 
TCPS and the surrogates, so that each substrate was submerged completely. The ATRP reaction 
was allowed to proceed for 1, 12, and 24 hours under argon atmosphere.  After ATRP, surrogates 
and TCPS plates were rinsed with 1% sodium chloride solution and deionized water and dried.  
Residual copper was removed from the ATRP-modified surfaces by washing alternately with 5 
mM ethylenedimaine tetracetic acid sodium salt (EDTA) and 5 mM calcium chloride solutions 
and finally with deionized water. 
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Contact Angle 
Static contact angles of deionized water were measured using a contact angle goniometer (Ramé-
Hart 200-F1 goniometer). Measurements were taken at three different locations and averaged.  
Streaming Potential Measurement 
Polymer coatings were prepared directly on polystyrene slides to measure surface charge.  An 
electrokinetic analyser SurPASS (Anton Paar GmBH) was used in clamping cell mode to acquire 
zeta potential values of the samples across a 3-10 pH range. Two titrations were performed for 
each sample, one proceeding from the neutral to the acidic range and another from the neutral to 
the basic range. 0.1 M hydrochloric acid and 0.1M sodium hydroxide were used as titrants.  
0.001 M potassium chloride was used as the electrolyte. pH changes were performed using an 
automated titration unit with pH being altered in steps of 0.3 with continuous stirring of the 
electrolyte solution. Streaming current was measured using Ag/AgCl electrodes and the 
helmohltz smoluchwski equation was used to compute the zeta potentials. Flow rates of 50-70 
ml/minute were used at a pressure of 400 mbar and a gap of 100 microns between the sample and 
the polypropylene reference standard. Samples were rinsed for 3 minutes in between 
measurements at different pH points. 
Atomic Force Microscopy (AFM)  
The surface roughness of the PMEDSAH coatings was quantified via atomic force microscopy 
(AFM) using a Dimension Icon (Bruker, Madison, WI). Measurements were taken in tapping 
mode at room temperature in air using NSC15 cantilevers (MikroMasch, San Jose, CA) with 
resonant frequency and spring constants of 20-75 N/m and 265-400 kHz, respectively as probe 
tips. Measurements were taken at 1 Hz scan rate over a 2x2 micron area. Roughness values in the 
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form of root mean square roughness (Ra) were acquired through a statistical analysis performed 
by the AFM software (NanoScope Analysis) by averaging over the scanned region. Three values 
were acquired for each sample and averaged. 
3.3.2 Preparation of Matrigel-coated Substrates 
      Matrigel (BD BioSciences) was diluted to a concentration of 0.1 mg/ml in cold Dulbecco’s 
modified Eagle’s medium/F12 (DMEM/F12; GIBCO) and then applied to tissue culture 
polystyrene (TCPS) dishes (35 mm; BD Falcon). The coating was allowed to polymerize during 
2 h incubation at room temperature. Before plating cells, excess matrigel-DMEM/F12 solution 
was aspirated and the dishes were washed with sterilized Dulbecco's phosphate buffered saline 
(D-PBS). 
3.3.3 hESC Culture 
hESCs (H9 and H1, WiCell Research Institute, Madison, WI; CHB10, Children’s Hospital 
Corporation, Boston, MA) were cultured on PMEDSAH with human-cell-conditioned medium 
(HCCM, Global Stem) supplemented with 5 ng/mL of human recombinant basic fibroblast 
growth factor (bFGF; Invitrogen™). Differentiated cells were mechanically removed using a 
sterile pulled-glass pipet under a stereomicroscope (LeicaMZ9.5, Leica Microsystems Inc., 
Buffalo Grove, IL). Undifferentiated colonies were cut and collected as small cell clusters into a 
1.5 mL centrifuge tube. After centrifugation and brief washing with PBS, cells were treated with 
0.5 mL 0.25% Trypsin-EDTA (GIBCO) at 37 °C. The trypsinization was terminated by the 
addition of 1ml HCCM and brief centrifugation.  The cell pellet was dispersed in HCCM 
supplemented with 5 ng/mL bFGF and 10 µM of ROCK inhibitor (Sigma) [26] and passed 
through a 40 µm nylon mesh cell strainer (BD Biosciences, Bedford, MA) to remove large cell 
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aggregates. Single hESCs were counted and 20,000 cells (2000 cells/ cm2) were plated on 
matrigel, PMEDSAH and three types of ATRP PMEDSAH (25nm, 105nm and 176nm thick) 
coated-dishes and cultured for 7 days. The culture medium was replaced every other day. Single 
hESCs were passaged once a week for 5 consecutive weeks using the same method without 
removing differentiated colonies before passage. 
3.3.4 Alkaline Phosphatase Assay 
An Alkaline Phosphatase Detection Kit (Millipore) was used for phenotypic assessment of 
hESC. Briefly, on day 7, cells were fixed with 4% paraformaldehyde in PBS for 1-2 minutes, 
then rinsed and incubated in staining solution in the dark at room temperature for 15 minutes.  
Cells were rinsed and covered with 1x PBS to prevent drying prior to quantitative analysis.  
Undifferentiated colonies were identified by specific alkaline phosphatase staining. 
3.3.5 Quantitative Analysis of Undifferentiated Colony Formation and the Total Cell 
Number 
ImageJ software (http://rsb.nih.gov/ij) was used to count the number and area of undifferentiated 
colonies stained by alkaline phosphatase. The total number of cells grown on each dish was 
counted with a hemocytometer at the time of passage during the 5 consecutive weekly passages.  
A theoretical yield of total cell number of hESCs obtained on different substrates was calculated 
assuming that all cells would be passaged each week instead of the only 20,000 single cells that 
were done. The theoretical yield of cells was determined with the formula CN(n+1)= CNn
TN(n+1)/20000, in which CN is the calculated total cell number, TN is the total cell number and n 
is the passage number.  
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3.3.6 Flow Cytometry Analysis  
hESCs cultured on different substrates from week 1 to 5 were washed with PBS and harvest by 
incubation in 0.25% trypsin-EDTA (GIBCO). The trypsinization was terminated by adding1ml 
HCCM and the cells were incubated first with human IgG to block un-specific binding and then 
with human/mouse SSEA-4 PE-conjugated antibody (R&D systems) and analyzed by flow 
cytometry. Analysis was carried out with MoFlo® Astrios™ (Beckman Coulter) using standard 
procedures. Background fluorescence and autofluorescence were determined using cells 
incubated with Mouse IgG1 phycoerythrin isotype Control (R&D systems).  
3.3.7 Immunofluorescence Staining  
Cells grown on different substrates were fixed in 4% paraformaldehyde for 30 min at room 
temperature and then permeabilized with 0.1% Triton X-100 for 10 min. Primary antibodies 
raised against SSEA-4 (Santa Cruz Biotechnology), OCT3/4 (Santa Cruz Biotechnology), SOX2 
(Millipore), TRA-1-60 (Santa Cruz Biotechnology), TRA-1-81 (Millipore), and NANOG 
(Abcam) were diluted in 1% normal serum and incubated overnight at 4°C and detected with 
respective secondary antibodies. Sample images were captured using a Nikon TE2000-S inverted 
microscope with a Nikon DS-Ri1 camera. 
3.3.8 RNA Isolation and Quantitative RT-PCR 
Cells grown on different substrates were manually scraped from dishes and pelleted by 
centrifugation.  RNA was isolated and purified using the RNA easy Mini-Kit (Qiagen) following 
the manufacturer’s protocol. RNA quality and concentration was checked with a Synergy NEO 
HTS Multi-Mode Microplate Reader (BioTek Instruments, Winooski, VT). 
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Reverse transcription from 1 mg of total RNA into cDNA was done using SuperScript™ III 
First-Strand Synthesis SuperMix (Invitrogen™). Quantitative PCR was performed using 
TaqMan probes (Applied Biosystems) and TaqMan Universal PCR Master Mix (Applied 
Biosystems) on 7900 HT Fast Real Time PCR system (Applied Biosystems). Gene expression 
data was normalized to the expression levels of GAPDH, and calculated using the delta-delta cT 
expression level. 
3.3.9 Analysis of hESC Pluripotency 
At passage 5, pluripotency of hESCs was tested by embryoid body (EB) formation and directed 
cell-lineage differentiation. EB formation was achieved by hESC clusters cultured in suspension 
in DMEM (Life Technologies) supplemented with 10% FBS for 10 days to promote 
differentiation. Directed cell-lineage differentiation was performed on matrigel using the 
following protocols [27]. hESCs were induced to differentiate in chemically defined medium 
(CDM) base consisting of DMEM/F12 (Invitrogen) supplemented with 1X N2 (Invitrogen), 1X 
B27 (Invitrogen), 0.11 mM 2-mercaptoethanol, 1 mM nonessential amino acids, 2 mM L-
glutamine, and 0.5 mg/ml BSA (fraction V; Sigma Aldrich). To induce definitive endoderm 
(pancreatic differentiation) 100 ng/ml human recombinant activin A (STEMGENT) was added to 
CDM and cells were cultured in this condition for 6 days, followed by culture in CDM without 
activin A for an additional 9 days. For mesoderm (cardiomyocyte differentiation) cells were 
cultured in CDM supplemented with 50 ng/ml human recombinant BMP4 (STEMGENT) and 50 
ng/ml human recombinant activin A (STEMGENT) for 4 days, then further cultured in CDM 
with no activin A and BMP4 for another 10 days. For ectoderm (neuronal differentiation), 100 
ng/ml human recombinant Noggin (STEMGENT) was added to the CDM and cells were 
cultured in this condition for 8 days. 
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3.3.10 Cytogenetic Evaluation 
After 5 weeks of cell culture, standard G-band analysis on at least 20 cells was performed on 
cells cultured on 105nm ATRP PMEDSAH by Cell Line Genetics (Madison, WI) using standard 
protocols. 
3.3.11 Data Analysis 
Three independent replicates for each experiment were performed. Two data sets were compared 
using unpaired student t-test function in Excel (Microsoft, Seattle, WA) to calculate p values.  
Multiple data sets were compared using one way ANOVA analysis followed by the Tukey’s post 
hoc test to calculate p values. Levels of statistical significance were set at p < 0.05. 
3.4 Results  
3.4.1 Differences in Properties of PMEDSAH Coatings  
PMEDSAH polymer coatings were fabricated using two different surface-initiated 
polymerization procedures: UVO-initiated free radical polymerization (UVO-grafting) [21] and 
atom transfer radical polymerization (ATRP) conducted at three different reaction times.  
Physicochemical comparison between these four coatings was based on film thickness, 
wettability, surface roughness and zeta potential measurements (Figure 3-1). The thickness of 
films prepared through UVO-grafting was of 25 ± 6.5 nm.  In contrast, ATRP-prepared coatings 
displayed a gradual augmentation in film thickness with increasing reaction time: 25 ± 3 nm in a 
1 hour-reaction; 105 ± 8 nm in a 12 hour-reaction; and up to 176 ± 18.2 nm in a 24 hour reaction 
(Figure 3-1A). The contact angle of UVO-grafted PMEDSAH was 16.6 ± 1.6°, while ATRP film 
thicknesses that ranged between 25 nm and 176 nm demonstrated an increase in the contact 
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angle from 21.9 ± 9.4° to 75.3 ± 4° (Figure 3-1B). In several studies, engineering roughness into 
soft cell culture substrates in the form of nano-grooves and pillars has been shown to play a role 
in mediating cell adhesion [28]. Thus, the roughness of the four coatings was quantified with a 
topographical examination using atomic force microscopy. Differences in roughness, as 
measured by root-mean-square roughness values, were not statistically significant among the 
four coatings (Figure 3-1A). The zeta potential of grafted PMEDSAH was less negative than 
ATRP coatings. In addition, the 25 nm and 176 nm thick PMEDSAH coatings exhibited more 
negative charge than the 105nm thick coating in the neutral range of pH values. The isoelectric 
point of the 105 nm thick ATRP coating shifted slightly to the right from that of the other two 
coatings, indicating that it was less negative in terms of charge (Figure 3-1C). 
3.4.2 Propagation of Undifferentiated hESCs Colonies 
Alkaline phosphatase activity was used to identify undifferentiated hESC colonies. When 
CBH10 hESCs were initially cultured as single cells on ATRP PMEDSAH with a surface 
thickness of 105 nm, the number of undifferentiated colonies was similar to that of the matrigel 
control group (Figure 3-2A, B). However, compared to the other experimental groups, a 
significantly higher number of colonies were detected on the 105 nm thickness group. No 
significant differences in colony surface area were observed among experimental groups (Figure 
3-2A, B).  Similar results were obtained with the H9 hESC line, which limits the possibility of a 
hESC line-specific effect (Figure 3-3).  Taken together, these results indicated that the gel 
architecture of PMEDSAH coatings influenced hESC colony formation. 
3.4.3 Expansion of hESCs 
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To quantify the impact of gel architecture on long-term expansion of hESCs, a consistent number 
(20,000) of hESCs cultured initially as single cells on matrigel, PMEDSAH and ATRP 
PMEDSAH (25 nm, 105 nm, 176 nm) were passaged weekly for five consecutive weeks.  Prior 
to each passage to newly coated dishes, the total cell number was quantified and flow cytometry 
was performed on a subset of cells to evaluate the expression of SSEA-4, a hESC marker (Figure 
3-4). The percentage of SSEA-4 positive cells ranged from 96.65% to 99.95% and was not 
statistically (p>0.05) different among the different substrates and passages. However, the total 
number of cells that adhered to matrigel decreased after each passage and cells on matrigel did 
not survive after four consecutive passages. In contrast, single hESCs cultured on ATRP 
PMEDSAH and grafted PMEDSAH continued to thrive with each passage. Growth of hESCs 
was particularly robust on the ATRP PMEDSAH with a 105 nm surface thickness that supported 
a significantly (p <0.05) higher total cell number than all other experimental groups (Figure 3-
2C). 
The hypothetical yield of total hESCs achieved after five passages on each substrate was 
calculated assuming that all cells obtained at each passage were sub-cultured, instead of the 
20,000 cells that were actually propagated. The theoretical yield of cells was determined using 
the formula CN(n+1)= CNn  TN(n+1)/20000. In this formula, CN was the calculated total cell 
number, TN was the total cell number in the determined week and n represented the culture week.  
Using this formula, it was estimated that on the 105nm thick-ATRP PMEDSAH, the expansion 
of 20,000 cells over a period of five weeks would yield up to 4.7x109 undifferentiated stem cells.  
This level of hESC expansion on the 105 nm thick-ATRP PMEDSAH was 33.6-, 1.6- and 12.7-
fold greater than the theoretical yield calculated when cultured on grafted PMEDSAH, 25 nm 
and 176 nm thickness-ATRP PMEDSAH, respectively (Table 3-1). These calculated total cell 
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numbers strongly demonstrated that modifying the gel architecture significantly facilitated the 
expansion of hESCs. 
3.4.4 hESC Pluripotency and Genomic Stability 
Quantitative RT-PCR analysis of cells after five passages demonstrated that RNA expression 
levels of hESC markers OCT4, SOX2, KLF4 and NANOG were similar among hESCs cultured 
on grafted PMEDSAH and ATRP PMEDSAH (25nm, 105nm, 176nm; Figure 3-5A).  
Immunofluorescent staining of OCT4 and SSEA-4 in hESCs was also strong when cultured on 
both grafted PMEDSAH and ATRP PMEDSAH (25 nm, 105 nm and 176 nm) coatings (Figure 
3-5B). Because 105 nm ATRP PMEDSAH demonstrated a stronger capacity to support hESC 
self-renewal and expansion, an additional hESC line was also cultured on 105 nm ATRP 
PMEDSAH during the same period of time. In addition to OCT4 and SSEA-4, primary 
antibodies to SOX2, NANOG, TRA-1-60 and TRA-1-81 were used for immunofluorescence 
staining of H1 hESCs and all stem cell markers were strongly expressed (Figure 3-5C). 
The pluripotency of hESCs cultured on the 105 nm thick-ATRP PMEDSAH was determined by 
embryoid body (EB) formation and directed cell-lineage differentiation after five passages. 
Clusters of hESCs cultured on 105 nm thick-ATRP PMEDSAH formed EBs when cultured in 
suspension and expressed genes representing endoderm, mesoderm and ectoderm (Table 3-2). 
Furthermore, specific cell-lineage differentiation was successfully directed in vitro with 
chemically defined conditions, as demonstrated by a significant increase in expression of 
representative genes for each germ layer: AFP FOXA2, PDX1 and SOX17 for endoderm; HESX1, 
NKX2-5 and TNN13 for mesoderm; and NES, NEUROD1, PAX6 and SOX1 for ectoderm (Figure 
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3-6). These results demonstrated that ATRP PMEDSAH with a 105 nm surface thickness 
supported the pluripotency of hESCs. 
Because chromosomal changes may occur during long-term culture of hESCs [29], the genetic 
stability of cells cultured on 105 nm thick-ATRP PMEDSAH was evaluated by standard G-band 
analysis after five passages. The results demonstrated a normal human male karyotype for the H1 
cell line (Figure3-5D). 
3.5 Discussion 
The evolution of hESC culture from feeder-cell dependence and non-defined conditions to 
feeder-free and defined microenvironments has been enabled by the development of new culture 
materials. Because of its strong capacity to support hESC and induced pluripotent stem cell 
(iPSC) growth with chemically-defined and xenogeneic-free medium, the PMEDSAH-coating 
has the potential to serve as a substrate to generate high numbers of clinical grade pluripotent 
stem cells [10]. Thus, the elucidation of mechanisms by which PMEDSAH is able to support 
hESC self-renewal, pluripotency and long-term propagation will not only advance our 
knowledge of pluripotent stem cell biology, but also increase the effectiveness of hESC and 
iPSC expansion on defined conditions for potential human applications. 
Because matrigel is the most commonly used feeder-free substrate for hESC culture, it was used 
as a control in our experiments. We found that the number of hESCs grown on matrigel 
decreased after each passage, which may be due to the poor survival of hESCs on matrigel after 
cell dissociation [26, 30]. In contrast, both grafted and ATRP PMEDSAH supported hESC 
expansion during the five-week expansion period.  In particular, the ATRP PMEDSAH with a 
105 nm surface thickness led to significantly higher total cell numbers compared to all other 
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experimental groups (Table 3-1). In addition, hESCs retained their pluripotency and a normal 
karyotype after multiple passages during culture, which indicates that hESCs maintained their 
unique characteristics and genetic stability.  These findings are well aligned with the long-term 
goal of large-scale production of clinical grade hESCs. 
The different surface preparations tested in this study affected the gel architecture of the 
substrates. The UVO-grafted PMEDSAH surface had thin, poly-dispersed and unassociated 
polymer brushes. Whereas the ATRP process was capable of producing thick and mono-
dispersed polymer brushes [31, 32]. Moreover, the gel architectures were also different among 
the three ATRP surfaces due to differences in the ATRP reaction time. These data suggest that 
the gel architecture of the 105 nm thick ATRP coating best supported hESC growth, supporting 
the hypothesis that gel architecture of the zwitterionic surface layer is capable of influencing the 
culture and expansion of hESCs. 
The thickness of PMEDSAH produced using a 1-hour ATRP reaction time was nearly equal to 
that of the UVO-grafted surface (Figure 3-1). However, the former was capable of expanding the 
stem cell population at a higher rate than the latter.  Interestingly, the 176 nm thick coating 
exhibited a lower capacity for hESC expansion than both the thinnest coating (25 nm) and the 
best-performing PMEDSAH surface for hESC expansion (105 nm). The molecular weight of the 
UVO-grafted films could not be precisely controlled due to the kinetics of conventional free 
radical polymerization, where the radical lifetime is short and the termination step is rapid [33].  
However, the molecular weight of ATRP films was controlled and augmented as the film 
thickness increased by longer ATRP reactions. Therefore, the observation that 105 nm thick 
ATRP films supported hESC self-renewal better than the other ATRP groups with reduced or 
increased thickness, suggests that an optimal range of molecular weight for synthetic polymer 
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coatings exists for the support hESC self-renewal. This finding is consistent with a recent study 
in which polymer molecular weight influenced hESC growth in a non-monotonic manner [18]. 
Another study comparing substrates with different chemical structures demonstrated that 
hydrophobic materials are less permissive for hESC adhesion [14]. Here, however, we 
investigated the effects of hydrophilicity on hESC behavior using PMEDSAH surfaces with 
identical chemical compositions with different degrees of wettability. The UVO- grafted and the 
25 nm ATRP-PMEDSAH, which have a contact angle of 16.6° and 21.9°, respectively, were the 
most hydrophilic surfaces tested.  The 176 nm thick ATRP coating, with a contact angle of 75.3°, 
was the least hydrophilic of all PMEDSAH surfaces tested. However, all three surface coatings 
demonstrated lower hESC expansion rates compared to the 105 nm thick ATRP-PMEDSAH 
coating, which had a contact angle of 43.7°. Thus, modifying the PMEDSAH surface to a 
moderate hydrophilicity led to better support of hESC growth than surfaces at the extremes of 
contact angle. 
The hydrophilicity of UVO-grafted PMEDSAH is attributed to water affinity of the anionic 
sulphonate and cationic quaternary ammonium present in their side chains. The tendency of these 
functional groups to be hydrated leads to water penetration, swelling of the polymer brush and a 
lower contact angle. For film thicknesses between 25 nm and 176 nm, the contact angle 
increased from 21.9° to 75.3° (Figure 3-1B). This transition from hydrophilic to hydrophobic 
behavior of PMEDSAH was first explained in terms of whether inter-chain associations 
dominate the hydration behavior of the polymer brush [34]. Differences in wettability between 
UVO-grafted and ATRP polymer coatings can be attributed to the effect of grafting density and 
polymer chain length on the balance of inter- and intra-polymer chain associations [35]. 
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Because neither grafting density nor molecular weight distribution can be precisely controlled 
[36] in UVO-grafted films, the resulting polymer brush is likely to be thin, poly-dispersed and 
unassociated. In the unassociated state, ionic attractions between the sulphonate and the 
ammonium groups in the side chains are not dominant, allowing the polymer to be fully hydrated, 
resulting in a low contact angle [37]. In contrast, ATRP coatings have a controllable and high 
grafting density that results in greater proximity of polymer chains and increased opportunities 
for short-range ionic interactions. The 25 nm films would exhibit only a slight degree of 
association behavior, as they do not have a sufficient number of ion-pairs and are therefore 
hydrophilic. The 105 nm and 176 nm coatings, being of higher molecular weight, have a greater 
number of ion pairs and are able to form stronger intermolecular associations that lead to 
dehydration and collapse of the brush. This ion-ion pairing prevents complete hydration of the 
ionic groups and is effective in sealing out water from the polymer coating. As the PMEDSAH 
polymer grows in length, more ion pairs are created, increasing the strength of the association, 
extent of water exclusion and contact angle [34] . 
In the absence of systematic intermolecular associations, the UVO-grafted PMEDSAH brush 
remains fully hydrated [37]. It was initially believed that water molecules in the polymer brush 
could reduce the zeta potential through charge screening. Thus, the higher isoelectric point of 
UVO-grafted PMEDSAH within the ATRP films was attributed to the lack of ion-pairing effects 
between polymer side chains. In the ATRP coated PMEDSAH films, the 25 nm and 176 nm 
thick ATRP-PMEDSAH coatings exhibited more cumulative negative charge than the 105 nm 
thick coating in the neutral range of pH values. The isoelectric point of the 105 nm thick ATRP 
coating was shifted to the right of the other two coatings, indicating that it was less negative in 
charge (Figure 3-1C). Since even the hydrophilic 25 nm coating had a highly negative surface 
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charge, differences in surface charge among the ATRP coatings could not be attributed to the 
level of hydration. The coatings with the highest and lowest degrees of ion-pairing (176 and 25 
nm, respectively) were similar in their surface charge with their zeta potential plots overlapping 
in the neutral region. For reasons not yet fully understood, the 105 nm PMEDSAH coating had 
the least negative surface charge among the three ATRP coatings and this may render this 
surface as more favorable for cell adhesion. 
It has been shown that surfaces with a roughness of Rq = 1 nm, which are categorized as smooth, 
support hESCs growth better than nano-rough surfaces with a Rq of 75-150 nm [22]. Our 
analyses of substrate roughness on all four surfaces showed a Ra lower than 2 nm and had no 
statistical differences among them, which suggested that all these surfaces could be considered as 
smooth surfaces. It has also been shown that an optimum range of surface charge is associated 
with maximal cell adhesion to metallic biomaterial surfaces [38]. In our study, it was also 
observed that an optimum range of surface charge of PMEDSAH supports hESC expansion. The 
105 thick-ATRP PMEDSAH films were more favorable for hESC expansion compared to the 
UVO-grafted films with a lower negative charge and to the 25 nm and 176 nm thick ATRP 
PMEDSAH films that exhibited a more negative charge. The more negatively charged 25 nm 
and 176 nm ATRP films may generate stronger repelling forces to cells, as cell membrane 
potential is typically negative, which may result in an adverse effect on hESC adhesion.  
However, this would not explain the lower cell expansion observed on UVO-grafted surfaces 
with the less negative charge. Thus, it is possible that hESCs prefer an optimum range of 
repelling forces. Alternatively, the UVO-grafted surfaces had unique gel architecture with 
polydispersed and unassociated polymer brushes compared to the well-uniformed ATRP surfaces.  
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If this were true, then the surface charge may not be the key factor leading to the differences of 
hESC expansion between UVO-grafted and ATRP PMEDSAH. 
Taken together, the observed trend in hESC expansion (105 nm thick PMEDSAH > 25 nm thick 
PMEDSAH > 176 nm thick PMEDSAH > UVO-grafted PMEDSAH) could not be attributed 
alone to a single physical property of the substrates studied here. Comparing thickness and 
contact angle helped establish that differences in gel architecture between coatings existed.  
Balance between ion-pairing driven inter-molecular association and hydration behaviors of 
PMEDSAH brushes may dictate the gel architecture adopted in each substrate. Thus, the data 
suggest that the 105 nm thick ATRP PMEDSAH coating possesses the optimal gel architecture 
for hESC expansion with its intermediate thickness, hydrophilicity, surface charge, and a 
moderate degree of inter-chain association. In addition to significantly higher efficiency in hESC 
expansion during long-term culture, the 105 nm ATRP-PMEDSAH has the following advantages 
compared to matrigel: defined molecular composition, more stably on long-term storage minimal 
lot-to-lot variability, ease of preparation and compatible with standard sterilization techniques.  
All of these feature make the 105 nm thick ATRP PMEDSAH a very promising substrate to 
obtain scalable populations of clinical grade hESCs. This could be accomplished by reducing the 
cell expansion time, production cost, as well as possible contamination and population drift 
under current culture conditions. 
Our results revealed differences in gel architecture between UVO-grafted PMEDSAH and in 
among ATRP-PMEDSAH substrates that point towards alterations in the balance of inter-
molecule associations between polymer chains. This in turn influences the interfacial properties 
of the substrate and exercises a profound effect on the culture and expansion of hESCs. While all 
four coatings were able to maintain their pluripotency over long-term culture, significant 
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differences in cell expansion were observed. The 105 nm thick ATRP-based coating was found 
to perform significantly better than the other three substrates. In conclusion, the physical 
properties influenced the ability of PMEDSAH to support hESC expansion. The newly 
developed 105 nm thick ATRP-PMEDSAH described here may be effective in the scalable 
production of hESCs for application in regenerative medicine. 
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3.6 Figures 
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Figure 3-1. Differences in properties of PMEDSAH coatings (A) Thickness (circles) and 
roughness (columns) of PMEDSAH coatings polymerized through UVO-grafting and ATRP. 
Thickness of ATRP coatings increased with ATRP reaction time. (1 hour-25 nm, 12 hours-105 
nm, 24 hours-176 nm) (B) Cartoons depict polymer conformations adopted by the four 
PMEDSAH coatings studied. Water molecules have been represented in yellow.  Differences in 
hydration and ion-pairing behaviour have been illustrated. Inset- Photographs of static contact 
angle measurements performed with deionized water on PMEDSAH coatings. Contact angle 
values are displayed below the respective images. (C) Comparison of zeta potential values of 
PMEDSAH coatings polymerized through UVO-grafting and ATRP. Credit: Xu Qian, et al. 
Biomaterials 2014;35:9581-90 
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Figure 3-2. Gel architecture influences the undifferentiated colony formation and 
expansion of hESCs (CHB 10 cells). (A) Undifferentiated colonies were identified by alkaline 
phosphatase assay after 7 days of culture on different substrates. (B) Plot of undifferentiated 
colony number ratio compared to Matrigel indicated ATRP PMEDSAH with a 105nm hydrogel 
thickness lead to a higher number of undifferentiated colonies compared to other experimental 
groups. Plot of undifferentiated colony area indicated that the areas of undifferentiated colonies 
cultured on different substrates had no significant differences. (C) Plot of total cell number ratio 
compared to Matrigel after 1 week and compared to grafted PMEDSAH after 5 weeks indicated 
ATRP PMEDSAH with a 105nm hydrogel thickness lead to a higher total cell number compared 
to other experimental groups. Data in (B) & (C) presented as mean ± standard deviation (SD) 
from three independent experiments (* p<0.05). Credit: Xu Qian, et al. Biomaterials 
2014;35:9581-90 
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Figure 3-3. Gel architecture influences the undifferentiated colony formation of hESCs (H9 
cells). Plot of undifferentiated colony number ratio compared to matrigel indicated ATRP 
PMEDSAH with a 105nm hydrogel thickness led to a higher number of undifferentiated colonies 
compared to other experimental groups. Plot of undifferentiated colony area indicated no 
significant differences among cells cultured on different polymer substrates. Data presented as 
mean ± SD from three independent experiments (* p<0.05). Credit: Xu Qian, et al. Biomaterials 
2014;35:9581-90 
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Figure 3-4. Expression of SSEA-4 in hESCs cultured on different substrates after multiple 
passages. hESCs cultured on different substrates from week 1 to week 5 were analyzed by flow 
cytometry to determine the percentage of SSEA-4 expressing cells. Background fluorescence and 
autofluorescence were determined using cells without treatment (-Control) and treated with 
Mouse IgG1 Phycoerythrin Isotype Control (PE).  Because cells grown on matrigel decreased 
after each passage, the amount of cells was not enough for flow cytometry from week 3. Credit: 
Xu Qian, et al. Biomaterials 2014;35:9581-90 
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Figure 3-5. Modified PMEDSAH supports hESC stemness and keeps the genomic stability. 
(A) Relative transcript levels of OCT4, SOX2, KLF4 and NANOG from hESCs cultured on 
grafted PMEDSAH and ATRP PMEDSAH after 5 passages had no significant differences. Data 
presented as mean ± SD from three independent experiments. (B) Fluorescence micrographs of 
colonies of hESCs cultured on grafted PMEDSAH and ATRP PMEDSAH showing expression 
of pluripotent markers after 5 passages. Primary antibodies OCT4 and SSEA-4 were used to 
detect the expression of these markers from hESCs cultured on grafted PMEDSAH and ATRP 
PMEDSAH (25nm, 105nm and 176nm). hESC cultured on 105nm ATRP PMEDSAH after 5 
passages (C) showed expression of pluripotent markers in fluorescence micrographs and (D) kept 
a normal karyotype. Credit: Xu Qian, et al. Biomaterials 2014;35:9581-90 
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Figure 3-6. Modified PMEDSAH supports hESC pluripotency. hESCs cultured on 105nm 
ATRP PMEDSAH after 5 passages retained pluripotency as demonstrated by induced specific 
lineage differentiation with expression of genes representing  different germ layers. Data 
presented in as mean ± SD from three independent experiments. Credit: Xu Qian, et al. 
Biomaterials 2014;35:9581-90 
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3.7 Tables 
 
     Table 3-1Calculated total cell number of hESCs cultured on different substrates  
 
 
 
 
 
Credit: Xu Qian, et al. Biomaterials 2014;35:9581-90 
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Table 3-2 Embryoid body (EB) formation with expression of genes representing different 
germ layers. EBs were formed from hESCs cultured on 105nm ATRP PMEDSAH after 5 
passages.  Quantitative RT-PCR showed increasing transcript levels of genes representing 
different germ layers from EBs compared to the undifferentiated hESCs grown on 105 nm 
ATRP PMEDSAH after 5 passages. 
   
 
 
 
Credit: Xu Qian, et al. Biomaterials 2014;35:9581-90 
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CHAPTER 4 
DPPA5 PROMOTES PLURIPOTENCY AND REPROGRAMMING BY 
REGULATING NANOG TURNOVER 
 
4.1 Abstract 
Although a specific group of transcription factors, such as OCT4, SOX2 and NANOG are known 
to play essential roles in pluripotent stem cell (PSC) self-renewal, pluripotency and 
reprogramming, other factors and the key signaling pathways regulating these important 
properties are not completely understood. Here, we demonstrate that the PSC marker 
Developmental Pluripotency Associated 5 (DPPA5) plays an important role in human PSC 
(hPSC) self-renewal and cell reprogramming in feeder-free conditions. Compared to PSCs grown 
on mouse embryonic fibroblasts (MEFs), cells cultured on feeder-free substrates, such 
as matrigel, laminin-511, vitronectin, or the synthetic polymer poly[2-(methacryloyloxy) ethyl 
dimethyl-(3-sulfopropyl) ammonium hydroxide] (PMEDSAH), had significantly higher DPPA5 
gene expression and protein levels. Overexpression of DPPA5 in hPSCs increased NANOG 
protein levels via a post-transcriptional mechanism. Co-immunoprecipitation, protein stability 
assays and quantitative RT-PCR, demonstrated that DPPA5 directly interacted, stabilized and 
enhanced the function of NANOG in hPSCs. Additionally, DPPA5 increased the reprogramming 
efficiency of human somatic cells to induced pluripotent stem cells (hiPSCs). Our study provides 
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new insight into the function of DPPA5 in hPSCs, and may further improve current protocols to 
enhance reprogramming efficiency into hiPSCs. 
4.2 Introduction 
Human pluripotent stem cells (hPSCs), which include embryonic stem cells (hESCs) derived 
from the inner cell mass of blastocyst-stage embryos, and induced pluripotent stem cells (hiPSCs) 
generated by reprogramming somatic cells through overexpression of key transcription factors 
[1-3], are a promising resource for regenerative medicine. An improved understanding of these 
pluripotent cells may also provide insight into early human embryonic development because they 
are able to indefinitely self-renew and differentiate into specialized cell types of all three germ 
layers and trophoectoderm. A key to unlocking this potential is a more advanced understanding 
of the molecular mechanisms governing hPSC self-renewal and the network of factors that 
enable pluripotency. Although it is known that an assembly of transcription factors, including 
OCT4, SOX2 and NANOG, play important roles in hESC self-renewal and pluripotency [4-7], 
the crucial signaling pathways and factors regulating hPSC biology are not completely 
understood.   
The Developmental Pluripotency Associated 5 (DPPA5) gene, also designated ESG1, belongs to 
the KHDC1/DPPA5/ECAT1/OOEP gene family. These genes encode structurally related proteins 
characterized by an atypical RNA-binding K Homology (KH) domain and are specifically 
expressed in mammalian oocytes and ESCs [8]. Because of its high expression in pluripotent 
stem cells, DPPA5 has been used as an informative marker for cell pluripotency and stemness [9-
14]. However, there is limited information regarding the function of DPPA5 in mouse or human 
ESCs [15].  
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The homeobox transcription factor NANOG has been proposed as a gatekeeper of pluripotency 
in hPSCs. Studies indicate that down-regulation of NANOG in hESCs induces differentiation [6], 
while overexpression of NANOG prevents neuroectoderm differentiation and blocks progression 
along endodermal and mesodermal lineages [16-18]. In methods to reprogram somatic cells into 
iPSCs, the addition of NANOG to the OCT4, SOX2, KLF4, and C-MYC (OSKM) reprograming 
cocktail enhances reprogramming kinetics [19]. Likewise, hiPSCs have been generated by the 
overexpression of NANOG in cooperation with the expression of OCT4, SOX2, and LIN28 [3]. 
In Chapter 3, we describe the studies to investigate the effects of hydrogel physical properties on 
the ability of synthetic polymer coatings to support hPSC self-renewal. Here in Chapter 4, our 
work is focusing on determining which molecules and signaling pathways play critical roles in 
supporting hPSC self-renewal on synthetic polymers. We used DPPA5 as a PSC marker to 
investigate the mechanism by which synthetic polymer coatings such as poly[2-
(methacryloyloxy) ethyl dimethyl-(3-sulfopropyl) ammonium hydroxide] (PMEDSAH) support 
hPSC self-renewal [20, 21]. Our data initially revealed higher expression of DPPA5 in hPSCs 
cultured on PMEDSAH compared to irradiated mouse embryonic fibroblasts (MEFs), the most 
widely used culture condition [22]. This finding led us to raise the hypothesis that DPPA5 has a 
unique role in hPSCs self-renewal when cultured on synthetic substrates. 
In this study, we first compared the gene expression and protein levels of DPPA5 in hPSCs 
cultured on MEFs and several feeder-free conditions. In response to DPPA5 overexpression, we 
found that NANOG protein levels were stabilized by DPPA5. Because of the central role of 
NANOG in hPSC pluripotency, we investigated the mechanism by which DPPA5 regulates 
NANOG and the effects of DPPA5 on NANOG target genes in hESCs. We also studied the 
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function of DPPA5 in the derivation of hiPSCs and found DPPA5 enhanced the reprogramming 
efficiency when combined with OCT4, SOX2, KLF4, and C-MYC. 
4.3 Materials and Methods 
4.3.1 Cell Culture Substrates Preparation  
All cell culture was performed in designated incubators at 5% CO2 and high humidity. Irradiated 
MEFs (GlobalStem) were plated at a density of 2 X 104 cells/cm2 on gelatin-coated tissue culture 
dishes. The fibroblast culture medium was composed of high-glucose DMEM (GIBCO), 10% 
fetal bovine serum (FBS; GIBCO), 1% nonessential amino acids (GIBCO), 1% GlutaMax 
(GIBCO) and 1% penicillin streptomycin (GIBCO).  
The synthetic surface PMEDSAH was prepared as described previously [23]. Briefly, through 
ultraviolet ozone (UVO)-initiated free radical polymerization in a fume hood with connections 
for argon, a 500 mL reaction vessel was degassed by vacuum for 1 hour. When the reaction 
vessel was being evacuated, a monomer solution consisting of 0.25 M MEDSAH (Sigma-Aldrich) 
was dissolved in a mixture of deionized water and ethanol (4:1, v/v). The solution was degassed 
for 40 minutes with an argon purge. After the reaction vessel and solvent were degassed, the 
monomer solution was transferred to a reaction vessel and heated to 68-70°C. While the reaction 
vessel was being heated, tissue culture polystyrene (TCPS) dishes (BD BioSciences) were 
activated by UVO treatment (Jetlight Inc.) for 40 minutes to create initiation sites on the surface. 
After activation, the dishes were transferred to a reaction vessel and the temperature was 
increased to 76-80°C. Surface-initiated polymerization occurred over a 2.5 hour time period 
under argon atmosphere at 76-80°C. Once the process was complete, TCPS dishes and control 
samples were removed from the reaction vessel, and rinsed in a 1% saline (w/v) solution at 50°C.  
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Matrigel (BD BioSciences) was diluted to a concentration of 100 µg/ml in cold Dulbecco’s 
modified Eagle’s medium/F12 (DMEM/F12; GIBCO) and then applied to TCPS dishes or flasks 
(BD BioSciences). The coating was allowed to polymerize during 2 hours incubation at room 
temperature. Before plating cells, excess matrigel-DMEM/F12 solution was aspirated and the 
dishes were washed with sterilized Dulbecco's phosphate buffered saline (D-PBS; GIBCO). 
Human laminin-511 (Biolamina) was diluted to a concentration of 10 µg/ml in PBS (GIBCO). 
Vitronectin (R&D Systems) was diluted to 5 µg/ml in PBS (GIBCO). Coating of Laminin and 
vitronectin was respectively applied to TCPS dishes following the manufacturer’s protocols. 
4.3.2 Cell Culture of hPSCs 
Unless otherwise specified, hESCs (H1 (NIH registration # 0043) and H9 (NIH registration 
number # 0062), WiCell Research Institute, Madison, WI; CHB10 (NIH registration number 
0009), Children’s Hospital Corporation, Boston, MA) and hiPSCs derived in our lab [24] from 
human gingival fibroblasts and foreskin fibroblasts, hGF2-iPSCs, hGF4-iPSCs and hFF-iPSCs 
were cultured on PMEDSAH, matrigel, human laminin-511, vitronectin and MEFs with hPSC 
culture medium (human-cell-conditioned medium (HCCM, Global Stem) supplemented with 5 
ng/mL of human recombinant basic fibroblast growth factor (bFGF; Invitrogen™) and 1% 
Antibiotic-Antimycotic (GIBCO)). The hPSC culture medium was replaced every other day. 
Differentiated cells were mechanically removed with a sterile pulled-glass pipet under a 
stereomicroscope (LeicaMZ9.5, Leica Microsystems Inc). Undifferentiated colonies were cut 
and passed as small cell clusters for three passages for each culture condition before analysis. 
4.3.3 MEF-conditioned Medium Preparation and Extracellular Matrix (ECM) Deposition 
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Twenty-four hours after plating irradiated MEFs at a density of 2 X 104 cells/cm2 on gelatin-
coated tissue culture dishes, fibroblast culture medium was replaced with hPSC culture medium, 
and collected the following day, and was labeled as MEF1-CM. Then, hPSC culture medium was 
replaced every other day and conditioned medium was collected again after 6 days (MEF7-CM). 
These MEF-conditioned media were stored at −20°C before being used in hPSC culture. MEF-
ECM deposits were prepared as described previously [22]. Briefly, irradiated MEFs were culture 
as described above and during the same period of time. At the time of isolating the ECM deposits, 
MEFs were washed twice with phosphate buffered saline (PBS), and then lysed in buffer 
containing 0.5% (v/v) of Triton X-100/PBS and 35 µL of ammonium hydroxide solution 
(NH4OH) per 100 mL for 5 minutes at room temperature. Plates with ECM deposited were 
washed three times with PBS before being used in cell culture. 
4.3.4 Microarray Analysis 
Total RNA (10 µg) from hESCs grown on PMEDSAH or MEFs was hybridized to Affymetrix 
Human Genome U133 Plus 2.0 microarray (Affymetrix; Santa Clara, CA) following the 
manufacturer's instructions. Data analysis was performed with a Robust Multi-array average 
algorithm that converted the plot of perfect match probe intensities into an expression value for 
each gene. Genes with different expression levels were detected by fitting a linear model to each 
probe-set and selecting those with a multiplicity-adjusted p < 0.05. 
4.3.5 RNA Isolation and Quantitative RT-PCR 
RNA was isolated and purified with the RNA easy Mini-Kit (Qiagen) following the 
manufacturer’s protocol. RNA quality and concentration was measured with a Synergy NEO 
HTS Multi-Mode Microplate Reader (BioTek Instruments, Winooski, VT). Reverse transcription 
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from 1 µg of total RNA into cDNA was done using SuperScript™ III First-Strand Synthesis 
SuperMix (Invitrogen™). Quantitative PCR was performed by TaqMan probes (Applied 
Biosystems) and TaqMan Universal PCR Master Mix (Applied Biosystems) on 7900 HT Fast 
Real Time PCR system (Applied Biosystems). Gene expression data was normalized to the 
expression levels of GAPDH, and calculated by the delta-delta cT expression level.  
4.3.6 Western Blot Analysis 
The following antibodies were used: OCT4 antibody (1:2,000; Santa Cruz Biotechnology Inc.), 
SOX2 antibody (1:1,000; Cell Signaling Technology), KLF4 antibody (1:1,000; Cell Signaling 
Technology), C-MYC antibody (1:1,000; Cell Signaling Technology), NANOG antibody 
(1:1,000; Cell Signaling Technology), DPPA5 antibody (2 µg/mL; R&D systems), α-tubulin 
antibody (1:3,000; Santa Cruz Biotechnology Inc.) and β-actin antibody (1:1,000; Cell Signaling 
Technology). Whole cell lysates were prepared from cells, separated on 10% SDS-
polyacrylamide gel, and transferred to polyvinylidene difluoride membranes. The membranes 
were incubated with 5% milk in TBST (w/v) for 0.5 hour and then incubated with primary anti-
bodies overnight at 4°C. Blots were incubated with horseradish peroxidase- coupled secondary 
antibodies (Promega; R&D systems) for 1 hour, and protein expression was detected with 
SuperSignal West Pico Chemiluminescent Substrate or SuperSignal West Femto 
Chemiluminescent Substrate (Thermo Scientific). ImageJ software (http://rsb.nih.gov/ij) was 
used for quantification of Western blots. 
4.3.7 Directed Cell-lineage Differentiation and Embryoid Body (EB) Formation 
EB formation was achieved by culturing clusters of hESCs in suspension with DMEM (GIBCO) 
supplemented with 10% FBS for 10 days. Directed cell-lineage differentiation was performed on 
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matrigel coated dishes using the following protocols [25]. hESCs were induced to differentiate in 
chemically defined medium (CDM) base consisting of DMEM/F12 (GIBCO) supplemented with 
1X N2 (Invitrogen), 1X B27 (Invitrogen), 0.11 mM 2-mercaptoethanol, 1 mM nonessential 
amino acids, 2 mM L-glutamine, and 0.5 mg/ml BSA (fraction V; Sigma Aldrich). To induce 
definitive endoderm (pancreatic differentiation), 100 ng/ml human recombinant activin A 
(STEMGENT) was added to CDM and cells were then cultured in this condition for 6 days, 
followed by culture in CDM without activin A for another 9 days. For mesoderm (cardiomyocyte 
differentiation), cells were cultured in CDM supplemented with 50 ng/ml human recombinant 
BMP4 (STEMGENT) and 50 ng/ml human recombinant activin A (STEMGENT) for 4 days, 
then further cultured in CDM without activin A and BMP4 for an additional 10 days. For 
ectoderm (neuronal differentiation), 100 ng/ml human recombinant Noggin (STEMGENT) was 
added to the CDM and cells were cultured for 8 days.  
4.3.8 Retrovirus Production and Transduction into Cells  
Retrovirus (10X) was produced with the plasmids (pMXs-hOCT3/4, pMXs-hSOX2, pMXs-hKLF4, 
pMXs-hC-MYC, pMXs-DPPA5 and pMXs-GW (as control), respectively; Addgene plasmid #: 
17217, 17218, 17219, 17220, 13352 and 18656) by University of Michigan Vector Core using 
standard protocols. Unless otherwise specified, after trypsinization, 2 X 104 single hPSCs were 
plated on a matrigel-coated 60 mm TCPS dish in hPSC culture medium supplemented with 10 
µM of Rho-associated coiled coil forming protein serine/threonine kinase (ROCK) inhibitor 
(Sigma-Aldrich). Besides, 1.5 X 105 fibroblasts were plated on a 35 mm TCPS dish in fibroblast 
culture medium. Cells were infected by 1X viruses plus polybrene (10 µg/mL; Sigma-Aldrich) 
when the confluency reached about 60%.  
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4.3.9 DPPA5 Overexpression 
Fibroblasts and hPSCs were infected by DPPA5 retroviruses using the method described above. 
In addition, fibroblasts were also transfected in a 35 mm TCPS dish with 2 µg pCMV6-Entry 
plasmid containing DPPA5 human cDNA ORF Clone (OriGene) using FuGENE6 (Promega). 
The construct pCMV6-Entry (OriGene) was used as control. 
4.3.10 Co-immunoprecipitation 
Immunoprecipitation (IP) was performed using the ImmunoCruz™ IP/WB Optima C System 
(Santa Cruz Biotechnology) following the manufacturer’s protocol. Briefly, hESCs protein 
extracts were prepared in CHAPS lysis and IP buffer (FIVEphoton Biochemicals) with protease 
inhibitor (FIVEphoton Biochemicals) and phosphatase inhibitor (FIVEphoton Biochemicals). 
hESC lysate (700 µg of total protein) was precleared with Preclearing Matrix C-mouse (Santa 
Cruz Biotechnology) for 1.5 hours at 4°C on a rotator. Meanwhile, 2.6 µg NANOG-specific 
antibody (Abcam) or normal mouse IgG (Santa Cruz Biotechnology) were mixed and incubated 
to form IP antibody-IP matrix complex and the control-IP matrix complex, respectively. After 1 
hour of incubation at 4°C on a rotator, IP antibody-IP matrix complex was washed with PBS 
(GIBCO). The supernatant was discarded after centrifugation. The precleared hPSCs lysate 
supernatant was transferred after centrifugation to the pelleted IP antibody-IP matrix complex 
and incubated at 4°C on a rotator overnight. After incubation and centrifugation, pelleted matrix 
was washed with PBS and Western blot analysis was performed to detect the interaction between 
NANOG and DPPA5 proteins. Whole hPSCs lysate was used as input. 
4.3.11 Protein Stability Assay 
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hPSCs were infected with DPPA5 or control (pMXs-GW) retroviruses. After 72 hours, 
cycloheximide (CHX; Sigma-Aldrich) was added to the culture media at a concentration of 45 
µg/ml. CHX treatment lasted until cells were subsequently harvested at different time points (0.5 
hours, 1 hours, 1.5 hours after CHX addition). Equal amounts of protein were loaded from each 
treated sample and analyzed by Western blot assays. 
4.3.12 Immunofluorescence Staining 
Cells were fixed in 4% paraformaldehyde for 30 minutes at room temperature and then 
permeabilized with 0.1% Triton X-100 for 10 minutes. Primary antibodies against DPPA5 (R&D 
systems) and NANOG (Abcam) were diluted in 1% normal serum (v/v) and incubated overnight 
at 4°C and detected with respective secondary antibodies.  Sample images were captured using a 
Nikon TE2000-S inverted microscope with a Nikon DS-Ri1 camera, or using Nikon confocal 
microscope system A1+. 
4.3.13 Derivation of hiPSCs 
For the control group, human gingival fibroblasts (hGF2) were infected on day 0 by retroviruses 
(OCT4, SOX2, KLF4 and C-MYC) using the method described above. On day three, cells were 
trypsinized and passed to matrigel coated flasks (75 cm2). At that time, the fibroblast culture 
medium was replaced by hPSC culture medium supplemented with 10 µM of ROCK inhibitor 
(Sigma-Aldrich). The hPSC culture medium with ROCK inhibitor was refreshed every day until 
day 23, when cells were fixed and stained for alkaline phosphatase. The following experimental 
groups were analyzed: fibroblasts infected by retroviruses (OCT4, SOX2, KLF4 and C-MYC) on 
day 0. In addition, fibroblasts were infected with retroviruses carrying DPPA5 on day 0, day 6, 
day 9 and day 12, respectively. 
! 
!
78 
4.3.14 Alkaline Phosphatase Assay 
An Alkaline Phosphatase Staining Kit (STEMGENT) was used for phenotypic assessment of 
hiPSCs. Briefly, on day 23 after fibroblasts were infected with OCT4, SOX2, KLF4 and C-MYC 
viruses, cells were fixed with Fix Solution for 2-5 minutes, then rinsed and incubated in AP 
Substrate Solution in the dark at room temperature for 15 minutes. Cells were rinsed and covered 
with 1 X PBS to prevent drying before quantitative analysis. hiPSC colonies were identified by 
positive alkaline phosphatase staining and morphological characteristics of colonies such as: well 
defined borders and high nuclei/cytoplasmic ratio. 
4.3.15 Data Analysis 
Three independent replicates of each experiment were performed. Two data sets were compared 
using unpaired student t-test function in Excel (Microsoft, Seattle, WA) to calculate p-values. 
Multiple data sets were compared using one-way ANOVA analysis followed by the Tukey’s 
post-hoc test to calculate p-values. Level of statistical significance was set at p < 0.05. 
4.4 Results  
4.4.1 DPPA5 Expression is Higher When hPSCs are Cultured on Feeder-free Substrates 
Than on MEFs  
To investigate the mechanism by which synthetic substrates such as PMEDSAH support hPSC 
self-renewal, we compared the gene expression of hESCs cultured on PMEDSAH versus on 
irradiated MEFs, after 3 consecutive passages. Microarray and Quantitative RT-PCR analysis 
demonstrated that DPPA5 gene expression levels were significantly higher in hESCs cultured on 
PMEDSAH compared to on MEFs, while the expression of other pluripotency-related factors 
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such as OCT4, SOX2, KLF4, C-MYC and NANOG showed no significant differences (Figure 4-1, 
Figure 4-2A). Similar results were obtained with the CHB10 hESC line and three independent 
hiPSC lines (Figure 4-2B). Western blot analysis demonstrated that protein levels of DPPA5 and 
NANOG were higher in hPSCs cultured on PMEDSAH compared to MEFs, while other 
pluripotency-related factors showed no significant differences (Figure 4-2C). The gene 
expression of DPPA5 of hPSCs was then compared to cells cultured on MEFs and other feeder-
free conditions (matrigel, laminin-511 and vitronectin). Quantitative RT-PCR analysis 
demonstrated higher gene expression of DPPA5 in hPSCs grown on feeder-free substrates 
compared to cells cultured on MEFs, while no significant RNA expression differences were 
observed among hESCs cultured in these feeder-free conditions (Figure 4-2D). 
Previously, we demonstrated that both the extracellular matrix (ECM) and soluble factors 
secreted by MEFs significantly impact the self-renewal of hESCs [22]. Therefore, we 
hypothesized that the ECM and soluble factors secreted by MEFs may inhibit DPPA5 expression 
in hPSCs, compared to feeder-free conditions. MEF-conditioned medium and ECM deposits 
were prepared on TCPS dishes as described in the Materials and Methods section, and used to 
cultured hESCs for three passages in a combinatorial experiment. The combination of 
PMEDSAH and HCCM was set as the control culture condition. In addition, cells were cultured 
on PMEDSAH plus day 1 or day 7 MEF-conditioned medium, and day 1 or day 7 MEF-ECM 
plus HCCM. The RNA expression of OCT4 was used as an indicator of the undifferentiated state 
of hESCs. Quantitative RT-PCR analysis demonstrated that, compared to the control condition, 
hPSCs expressed lower levels of DPPA5 in PMEDSAH with day 7 MEF-conditioned medium 
(Figure 4-3A), indicating that soluble factors secreted by MEFs inhibit DPPA5 expression. 
Similarly, compared to the control condition, the expression of DPPA5 was lower in hPSCs 
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cultured on MEF-ECM plus HCCM (Figure 4-3B), indicating that the ECM deposited by MEFs 
also inhibits DPPA5 expression in hPSCs. Taken together, these data suggested that soluble 
factors and ECM deposited by irradiated MEF inhibits the gene expression and protein levels of 
DPPA5 in hPSCs.   
We analyzed DPPA5 gene expression levels in hPSCs and their differentiated derivative cells. 
Quantitative RT-PCR demonstrated that DPPA5 expression levels were significantly up-
regulated in hiPSCs compared to their corresponding parental fibroblasts (Figure 4-4A).  When 
compared to undifferentiated hESCs, DPPA5 expression levels significantly decreased after 
embryoid body (EB) formation (Figure 4-4B) and in cells induced to endodermal, mesodermal 
and ectodermal lineages (Figure 4-4C). Cell lineage differentiation and EB formation was 
confirmed by the increasing expression of factors representative of each germ layer (Figure 4-5, 
Table 4-1). Our finding that DPPA5 expression was higher in undifferentiated hPSCs compared 
to differentiated cells is consistent with other studies that used DPPA5 as a PSC marker [9, 12-14, 
26-29]. This specific expression pattern suggested that DPPA5 may play an important role in 
hPSC self-renewal and pluripotency. 
4.4.2 DPPA5 Regulates NANOG Protein Levels 
The higher expression of DPPA5 in hPSCs cultured under feeder-free conditions compared to 
MEFs provoked our interest in elucidating the function of DPPA5. Overexpression of DPPA5 in 
fibroblasts did not significantly affect gene expression of OCT4, SOX2, KLF4, C-MYC and 
NANOG (Figure 4-6A). However, in addition to detecting a significant increase in DPPA5 
protein levels, we also demonstrated an increase in NANOG protein levels via Western blot 
analysis (Figure 4-6B). No changes in protein levels were observed for other pluripotency-
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related factors. The same pattern was observed when DPPA5 was overexpressed in hESCs. 
NANOG protein levels dramatically increased without significant changes in gene expression 
(Figure 4-6C, D). These data indicated that DPPA5 functions as a positive regulator of NANOG 
protein at the post-transcriptional level. 
4.4.3 DPPA5 Protein Interacts with and Stabilizes NANOG Protein 
We next investigated the extent to which DPPA5 may affect NANOG protein levels in hPSCs. 
Immunofluorescence staining and confocal microscopy analysis illustrated that DPPA5 was 
localized in both the cytoplasm and nucleus of hESCs. In addition, DPPA5 co-localized with 
NANOG in the nucleus (Figure 4-7A), indicating a possible interaction between these two 
proteins. Co-immunoprecipitation was performed to investigate this possible interaction between 
DPPA5 and NANOG in hESCs. Western blot analysis demonstrated that NANOG was 
successfully pulled down by a NANOG IP antibody-IP matrix complex. Concurrent with this 
finding, DPPA5 was strongly co-precipitated by NANOG, indicating the interaction between 
DPPA5 and NANOG protein. No protein was co-precipitated by the normal mouse IgG-IP 
matrix complex, suggesting that nonspecific binding did not play a role in these experiments 
(Figure 4-7B). Protein stability assays were then performed to identify the extent to which 
DPPA5 inhibits NANOG protein degradation in hESCs. Western blot analysis showed that the 
degradation of NANOG was significantly delayed by DPPA5 overexpression in the presence of 
cycloheximide (Figure 4-7C). Taken together, these data indicated that DPPA5 interacts with and 
stabilizes NANOG in hPSCs. 
4.4.4 DPPA5 Enhances the Function of NANOG on Its Target Genes 
! 
!
82 
Recent studies reported that NANOG increases the transcription of SALL4, and represses the 
transcription of GATA6 and SOCS3 through binding to their proximal gene promoters [30-34]. 
To study the extent to which DPPA5 enhances the function of NANOG in hPSCs, we examined 
the expression of NANOG target genes (SALL4, GATA6 and SOCS3) in response to DPPA5 
overexpression (Figure 4-6C, D). We found that gene expression of SALL4 was increased, while 
GATA6 and SOCS3 was repressed after DPPA5 overexpression (Figure 4-8). This evidence 
suggested that DPPA5 not only increased NANOG protein levels through post-translational 
stabilization, but also facilitated the function of NANOG on its target genes. 
4.4.5 DPPA5 Increases hiPSC-reprogramming Efficiency 
Because of the stabilizing action of DPPA5 on NANOG in hESCs, and the critical role of 
NANOG on hPSCs self-renewal and in the generation of hiPSCs [3, 19], we investigated 
whether DPPA5 would have a positive effect during reprograming of fibroblasts into hiPSCs. 
DPPA5 was added to the OCT4, SOX2, KLF4, and C-MYC cocktail (Figure 4-9) to determine its 
effect on reprogramming. Retroviruses (OCT4, SOX2, KLF4, and C-MYC) were used to infect 
fibroblasts in both control and experimental groups on day 0. Experimental group cells were 
additionally infected with retroviruses encoding DPPA5 on day 0, day 6, day 9 and day 12 
(experimental group-d0+D, d6+D, d9+D and d12+D, respectively). On day 23, iPSC colonies 
were identified by positive alkaline phosphatase staining and morphological characteristics 
(Figure 4-9C). Surprisingly, we found that the transduction of DPPA5 retroviruses on day 6, day 
9, day 12, but not day 0, significantly enhanced the generation of hiPSC colonies compared to 
controls, indicating that DPPA5 increases iPSC-reprogramming efficiency of OCT4, SOX2, 
KLF4, and C-MYC. Clusters of hiPSCs formed EBs when cultured in suspension and expressed 
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genes representing endoderm, mesoderm and ectoderm (Table 4-2, 4-3), indicating the 
pluripotency of these cells. 
4.5 Discussion 
In this study, we performed a comprehensive analysis of the role of DPPA5 in hPSCs and 
identified new functions of DPPA5 in hPSC biology, NANOG regulation and iPSC-
reprogramming.   
The potential for successful therapeutic application of hPSCs and their derivatives is based on 
the ability to develop clinically compliant strategies for large-scale production of therapeutically 
relevant cells [35-37]. Currently, the large-scale expansion of hPSCs is limited by xenogeneic 
components and poorly defined culture conditions that utilize feeder cells and other animal-based 
products to support hESC self-renewal [1, 38, 39]. To overcome these limitations, the use of 
human recombinant proteins like Laminin and Vitronectin have been tested for long-term 
maintenance of hESCs [39, 40]. Moreover, synthetic substrates such as PMEDSAH [20, 21] 
have demonstrated great potential for large-scale propagation of hESCs [42]. Our data suggest 
that MEF conditions, including the synthesis of soluble factors and the deposition of an ECM, 
inhibit DPPA5 expression in hPSCs compared to feeder-free culture conditions. These findings 
are consistent with a recent study that showed the capacity of γ-irradiated MEFs to support hESC 
self-renewal is compromised over time due to changes in the secretion of soluble factors and 
ECM of MEFs [22]. These data support the trend in the evolution of hPSC culture from feeder-
cell dependence and ill-defined conditions, to feeder-free and defined microenvironments [43].  
Pluripotency and self-renewal are maintained in PSCs by a network of interacting transcription 
factors, influenced by specific signaling pathways [44], and may be different depending on the in 
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vitro culture conditions. Our data clearly identifies DPPA5 as a new component in this 
regulatory network of pluripotency that is differentially expressed depending on the culture 
conditions. DPPA5 is highly expressed in feeder-free conditions (PMEDSAH, matrigel, laminin-
511 and vitronectin) compared to feeder-dependent conditions (irradiated MEFs), suggesting that 
DPPA5 may play a more important role in hPSC maintenance under feeder-free conditions. Our 
finding that the molecular mechanisms supporting hPSC pluripotency are different depending on 
the culture conditions, as well as the species differences between human and mouse ESCs, may 
be, in part, responsible for a previous study that found no significant impact on mouse ESC self-
renewal when cultured on MEFs and when DPPA5 was knocked out in these cells [11]. 
The identification of a functionally significant role for DPPA5 in hPSC self-renewal is essential 
for our understanding of the mechanism by which feeder-free conditions are able to support 
hPSC self-renewal. This is especially true since the use of hPSCs in regenerative medicine will 
likely be dependent on expanding these cells in xenogenic, feeder-free conditions. Our data 
indicate that in hPSCs, DPPA5 regulates NANOG protein stability and enhances the function of 
NANOG on its target genes. This new finding that up-regulation of NANOG by DPPA5 is 
important because of the central role of NANOG in the pluripotency regulatory network in PSCs. 
NANOG is a homeodomain protein that binds to DNA and regulates the transcriptional levels of 
other genes, such as SALL4, GATA6 and SOCS3 [30-34, 45]. Previous findings demonstrating 
that down-regulation of NANOG in hESCs induces differentiation [6], while its overexpression 
prevents differentiation [16-18], suggest that sufficient levels of NANOG are critical for hPSC 
self-renewal. Here, we demonstrate that DPPA5 may be a significant contributor in maintaining 
NANOG protein levels in hPSCs. Moreover, our finding that NANOG target gene expression is 
impacted by DPPA5 overexpression in hPSCs further suggests that the increased NANOG 
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protein stability by DPPA5 does actively function in hPSCs. Together, our study suggests that 
DPPA5 plays an important role in supporting hPSC self-renewal by facilitating the protein levels 
of NANOG, a master transcriptional regulator for hPSC pluripotency. DPPA5 inhibits hPSC 
differentiation by stabilizing NANOG protein levels and enhancing the up-regulatory effects of 
NANOG on SALL4, a transcription factor required for ESC pluripotency, and down-regulatory 
effects of NANOG on GATA6 and SOCS3, well-known NANOG target genes that function in 
early stages of differentiation [34, 46, 47].  
Another novel and potentially important finding is the mechanism by which DPPA5 facilitates 
NANOG protein levels. Previous studies have reported transcriptional regulation of NANOG by 
other pluripotency-related factors such as OCT4, SOX2 and KLF4 [48, 49]. Meanwhile, DPPA5 
has been reported to be an RNA binding protein because it contains a KH domain [8]. 
Interestingly, we found that NANOG protein levels increased after DPPA5 overexpression 
without significant changes at NANOG mRNA levels. We also found that both mRNA and 
protein levels of other key pluripotent-related transcription factors (OCT4, SOX2 and KLF4) 
remained unchanged after DPPA5 overexpression. These findings led us to raise the hypothesis 
that DPPA5 directly interacts with and stabilizes NANOG proteins, which is supported by the 
co-immunoprecipitation and protein stability results. In support of these findings, a previous 
study showed that DPPA5 does not bind to, and regulate NANOG RNA after an 
immunoprecipitation-microarray screening [15]. In addition, our findings of the post-
translational regulation of NANOG are consistent with other studies showing that, like other 
pluripotency-related transcription factors such as OCT4, KLF4 and C-MYC, NANOG is also an 
unstable protein with a relatively short half-life in hPSCs. These transcription factors are 
degraded through ubiquitin-dependent proteolysis [50-54], while proteasome inhibitors are able 
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to block NANOG protein degradation in hPSCs and extend its half-life [55]. Our findings that 
DPPA5 interacts with and stabilizes NANOG provide an additional model of regulation of 
NANOG in hPSCs, suggesting that in addition to the broadly investigated transcriptional 
regulation of pluripotency-related transcription factors, post-translational regulation also plays a 
role in the hPSC pluripotency regulatory network. Thus, this regulatory model not only supports 
the hypothesis that DPPA5 is able to regulate NANOG, but also furthers our understanding of 
the molecular mechanisms that define hPSC pluripotency. We also observed that DPPA5 protein, 
like NANOG and other pluripotency-related factors, is degraded in a rapid manner in hPSCs  
Human iPSCs reprogrammed from adult somatic cells by the process of induced pluripotency, 
holds great potential for disease modeling, drug screening and cell replacement therapy [56]. 
Currently, hiPSC-reprogramming is significantly limited by the low iPSC generation efficiency. 
We found that the addition of DPPA5 to the reprogramming cocktail (OCT4, SOX2, KLF4 and 
C-MYC: OSKM) increased the generation of iPSCs greater than 3-fold when compared to 
controls. This identification of the function of DPPA5 in iPSC generation suggests that DPPA5 
has potential for improving our current reprogramming techniques by decreasing the 
reprogramming time, production cost, as well as reducing the risk of contamination by 
shortening the length of the reprogramming process. Our data demonstrate that, compared to the 
OSKM control group, DPPA5 enhances iPSC-reprogramming efficiency when transduced into 
cells at 6, 9 or 12 days after initial OSKM cocktail treatment, whereas the reprogramming 
efficiency remains the same compared to the OSKM control group, if DPPA5 is over-expressed 
together with OSKM on day 0. This observation suggests that DPPA5 may have an optimal time 
window for being overexpressed in the cells to efficiently promote iPSC-reprogramming and 
may be related to the timing of NANOG expression in the reprogramming process. The central 
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role of NANOG in reprogramming of somatic cells into iPSCs [3, 19, 57, 58], combined with our 
finding that DPPA5 regulates NANOG protein levels, suggest that DPPA5 may promote hiPSC-
generation efficiency by enhancing NANOG and its function during this optimal time. This new 
finding is consistent with a recent study showing the benefit of sequential introduction of 
reprogramming factors [59] in which a sequential EMT-MET (epithelial-to-mesenchymal 
transition followed by mesenchymal-to-epithelial transition) mechanism optimizes 
reprogramming. Taken together, our data suggest the important function of DPPA5 in iPSC 
generation and extends our knowledge of iPSC-reprogamming, and may further advance our 
current reprogramming protocols. 
In this study, we provide new molecular insight into the function of the pluripotent stem cell 
marker DPPA5 in hPSCs. In vitro culture conditions influence the expression of DPPA5 in 
hPSCs. The ECM deposited by irradiated MEFs, as well as secreted soluble factors, inhibit the 
expression of DPPA5 in hPSCs, while its expression and function is permissive under feeder-free 
conditions. DPPA5 stabilizes protein levels and enhances the function of NANOG, a key 
transcription factor for hPSC pluripotency. Finally, DPPA5 increases the reprogramming 
efficiency of somatic cells into human iPSCs when transduced with OCT4, SOX2, KLF4 and C-
MYC. In conclusion, DPPA5 plays an important role in supporting hPSC self-renewal and 
reprogramming. Our findings advance our knowledge of hPSC biology and offer improvements 
to current protocols in hPSC maintenance and reprogramming, which may contribute to the 
future application of these cells in regenerative medicine. 
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4.6 Figures 
 
 
 
 
Figure 4-1. Gene expression differences between hESCs cultured on PMEDSAH versus on 
MEFs Out of 54674 analyzed by microarray, 222 genes were found expressing at significantly 
different levels between hESCs cultured on PMEDSAH and MEFs. The gene expression of 
DPPA5 was significantly higher in hESCs cultured on PMEDSAH compared to on MEFs, while 
the expression of other pluripotency-related factors such as OCT4, SOX2, KLF4, C-MYC and 
NANOG showed no significant differences. 
Gene expression PMEDSAH vs MEF 
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Figure 4-2. Differences in DPPA5 gene expression and protein levels in hPSCs cultured on 
irradiated MEFs and feeder-free substrates. (A) Relative transcript levels of DPPA5 were 
higher in hESCs (H9) cultured on PMEDSAH compared to on MEFs, while relative transcript 
levels of OCT4, SOX2, KLF4, C-MYC and NANOG showed no significant differences in 
expression. (B) Relative transcript levels of DPPA5 were higher in multiple types of hPSCs (H9, 
CHB10, hFF-iPSCs, hGF2-iPSCs, and hGF4-iPSCs) cultured on PMEDSAH compared to MEFs. 
(C) Western blot analysis and relative signal intensity of DPPA5, NANOG, OCT4, SOX2, KLF4 
and C-MYC proteins in hESCs cultured on MEFs and PMEDSAH. α-tubulin was used as a 
loading control. (D) Compared to when cultured on MEFs, the relative transcript levels of 
DPPA5 were higher in hESCs (CHB10) cultured on feeder-free substrates such as PMEDSAH, 
matrigel, laminin and vitronectin. Plot data presented as mean ± standard deviation (SD) from 
three independent experiments (* p<0.05). Credit: Xu Qian, et al. Stem Cells. manuscript under 
revision  
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Figure 4-3. Soluble factors and ECM secreted by irradiated MEFs inhibited DPPA5 
expression in hPSCs compared to feeder-free conditions. The control culture condition was 
PMEDSAH (substrate) plus HCCM (medium). (A) Relative transcript levels of DPPA5 in 
hESCs cultured in control culture condition, PMEDSAH plus day 1 MEF-conditioned medium, 
and PMEDSAH plus day 7 MEF-conditioned medium. (B) Relative transcript levels of DPPA5 
in hESCs cultured in control culture condition, day 1 MEF-ECM plus HCCM, and day 7 MEF-
ECM plus HCCM. OCT4 gene expression was used as a marker indicating the undifferentiated 
state of the collected hESCs. Data presented as mean ± standard deviation (SD) from three 
independent experiments (* p<0.05). Credit: Xu Qian, et al. Stem Cells. manuscript under 
revision 
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Figure 4-4. Differences in DPPA5 expression between hPSCs and differentiated cells (A) 
Relative transcript levels of DPPA5 increased in iPSCs (hFF-iPSCs, hGF2-iPSCs and hGF4-
iPSCs) compared to corresponding parental fibroblasts. (B) Relative transcript levels of OCT4, 
SOX2 and DPPA5 decreased after embryoid body formation from hESCs. (C) Relative transcript 
levels of DPPA5 decreased after directed cell lineage differentiation from hESCs into 
endodermal, mesodermal and ectodermal derivatives. Data presented as mean ± standard 
deviation (SD) from three independent experiments (* p<0.05). Credit: Xu Qian, et al. Stem 
Cells. manuscript under revision 
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Figure 4-5. Induced specific lineage differentiation from hESCs with expression of genes 
representing different germ layers. Quantitative RT-PCR data presented as mean ± SD from 
three independent experiments (* p<0.05). Credit: Xu Qian, et al. Stem Cells. manuscript under 
revision 
 
! 
!
94 
 
Figure 4-6. The regulation of NANOG protein levels by DPPA5 in hPSCs (A) Relative 
transcript levels of DPPA5, NANOG, OCT4, SOX2, KLF4 and C-MYC between control 
fibroblasts and with DPPA5 overexpression. (B) Western blot analysis and relative signal 
intensity of DPPA5, NANOG, OCT4, SOX2, KLF4 and C-MYC proteins between control 
fibroblasts and with DPPA5 overexpression. β-actin was used as a loading control. (C) Relative 
transcript levels of DPPA5, NANOG, OCT4, SOX2, KLF4 and C-MYC between control hESCs 
and with DPPA5 overexpression. (D) Western blot analysis and relative signal intensity of 
DPPA5, NANOG, OCT4, SOX2, KLF4 and C-MYC proteins between control hESCs as control 
and with DPPA5 overexpression. β-actin was used as a loading control. Plot data presented as 
mean ± standard deviation (SD) from three independent experiments (* p<0.05). Credit: Xu 
Qian, et al. Stem Cells. manuscript under revision 
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Figure 4-7. Protein interaction and stabilization between DPPA5 and NANOG in hPSCs  
(A) Confocal microscopy images of immunofluorescence staining of hESCs with NANOG and 
DPPA5 primary antibodies. 4', 6-diamidino-2-phenylindole (DAPI) shows nuclear staining. The 
merged images indicate the co-localization of DPPA5 and NANOG in hESC nucleus. (B) Co-
immunoprecipitation of endogenous NANOG and DPPA5 in hESCs. hESCs extracts prepared in 
CHAPS lysis and IP buffer were immunoprecipitated with anti-NANOG or control IgG antibody. 
The immune complexes and the input (whole hESC lysate) were analyzed by Western blot with 
antibody specific to NANOG or DPPA5. (C) The protein levels of NANOG and DPPA5 at the 
indicated time points after CHX (45 µg/ml) treatment were analyzed in control hESCs or with 
DPPA5 overexpression. Western blot analysis and relative signal intensity indicated that DPPA5 
supports NANOG protein stability in hESCs. β-actin was used as a loading control. Plot data 
presented as mean ± standard deviation (SD) from three independent experiments (* p<0.05). 
Credit: Xu Qian, et al. Stem Cells. manuscript under revision 
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Figure 4-8. Regulation of the expression of NANOG target genes by DPPA5 in hPSCs 
SALL4 is positively regulated by NANOG. GATA6 and SOCS3 are negatively regulated by 
NANOG. Relative transcript level of SALL4 was higher, while GATA6 and SOCS3 were lower in 
hESCs with DPPA5 overexpression compared to control hESCs. Data presented as mean ± 
standard deviation (SD) from three independent experiments (* p<0.05). Credit: Xu Qian, et al. 
Stem Cells. manuscript under revision 
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Figure 4-9. DPPA5 increased hiPSC-reprogramming efficiency Bright-field images of (A) 
fibroblasts (hGF2) and (B) iPSCs (hGF2-iPSCs) reprogramed from fibroblasts. Scale bars, 100 
µm. (C) Bright-field image of an alkaline phosphatase positive iPSC (hGF2-iPSCs) colony after 
reprogramming. Scale bars, 500 µm. (D) Ratio of iPSC colony number demonstrated that day 6, 
day 9 and day 12-DPPA5 added groups (d6+D, d9+D, d12+D) had higher iPSC colony number 
compared to control group and day 0-DPPA5 added group (d0+D). In the control group, 
fibroblasts (hGF2) were transduced on day 0 by retroviruses (OCT4, SOX2, KLF4 and C-MYC). 
For experimental groups, retroviruses (DPPA5) were transduced into cells respectively on day 0, 
day 6, day 9 and day 12, in addition to OCT4, SOX2, KLF4 and C-MYC cocktail transduction on 
day 0. iPSC colonies were identified by positive alkaline phosphatase (ALP) staining and 
morphological characteristics of colonies as in (C). The number of the iPSC colonies was 
counted. Plot data presented as mean ± standard deviation (SD) from three independent 
experiments (* p<0.05). Credit: Xu Qian, et al. Stem Cells. manuscript under revision 
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4.7 Tables 
Table 4-1. Embryoid body (EB) formation from hESCs with expression of genes      
representing different germ layers 
 
!
Gene$ Relative$Transcript$Level$±$SD$
Endoderm$
PDX1! 28.24!±!3.70!
AFP! 42.18!±!4.39!
SOX17! 126.57!±!6.58!
FOXA2! 237.87!±!20.9!
Mesoderm$
HESX1! 11.2!±!1.88!
TNN13! 110.88!±!2.28!
NKX215! 122.86!±!17.48!
Ectoderm$
NES! 3.84!±!0.67!
SOX1! 34.76!±!1.98!
PAX6! 89.24!±!3.03!
NEUROD1! 683.19!±!89.38!
!
 
 
Credit: Xu Qian, et al. Stem Cells. manuscript under revision  
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Table 4-2. Embryoid body (EB) formation from Con-hiPSCs with expression of genes      
representing different germ layers 
 
 
 
 
 
Credit: Xu Qian, et al. Stem Cells. manuscript under revision 
 
!
Gene! Relative$Transcript$Level$±$SD!
Endoderm!
SOX17! 4.97!±!0.23!
FOXA2! 10.50!±!1.11!
AFP! 625.62!±!20.32!
Mesoderm!
T! 1.67!±!0.35!
HESX1! 3.42!±!0.13!
NKX215! 33.26!±!1.14!
!
NEUROD1! 3.12!±!0.13!
Ectoderm! SOX16 4.57!±!0.17!
! PAX66 9.93!±!0.47!
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Table 4-3. Embryoid body (EB) formation from d6+D-hiPSCs with expression of genes      
representing different germ layers 
 
 
 
 
 
Credit: Xu Qian, et al. Stem Cells. manuscript under revision 
 
!
Gene! Relative$Transcript$Level$±$SD!
Endoderm!
SOX17! 5.07!±!0.30!
FOXA2! 4.80!±!0.29!
AFP! 878.20!±!54.71!
Mesoderm!
T! 1.45!±!0.27!
HESX1! 4.45!±!0.14!
NKX215! 29.31!±!7.51!
!
NEUROD1! 7.77!±!0.08!
Ectoderm! SOX16 7.99!±!0.31!
! PAX66 18.84!±!2.43!
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CHAPTER 5 
CONCLUSION AND PROSPECTUS 
 
5.1 Summary 
Because human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) 
and human induced pluripotent stem cells (hiPSCs), can be directed to differentiate towards cells 
from all three germ layers and trophoectoderm, these cells have more potential and versatility 
than any adult stem cells. Recent advances in the culture and manipulation of hPSCs have 
improved the prospects for making meaningful progress in regenerative medicine, disease 
modeling, and drug screening [1]. For example, the development of synthetic polymers for hPSC 
culture offers xenogeneic-free and defined microenvironments that are very promising for the 
large-scale production of clinical-grade hPSCs and thus may provide an alternative cell source 
for tissue regeneration strategies [2-10]. These goals can only be achieved by the complete 
understanding of the mechanisms by which synthetic polymers support hPSC self-renewal, 
which however has not yet been well defined. 
In a previous study, we described the development of a completely synthetic polymer coating to 
culture and expand hESCs [4, 11]. We subsequently published the derivation of hiPSCs on the 
substrate, poly[2-(methacryloyloxy) ethyl dimethyl-(3-sulfopropyl) ammonium hydroxide] 
(PMEDSAH) [12]. Although other synthetic substrates have been developed for pluripotent stem 
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cell culture, PMEDSAH is currently the only fully synthetic substrate that contains no biologic 
components such as proteins, peptides or sugars. In this thesis, we studied the mechanism by 
which synthetic polymers PMEDSAH supports hPSC self-renewal from both the material and 
molecular biological approaches. 
From the material perspective, we investigated the extent to which the physical properties of 
PMEDSAH impact its capacity to support hPSC self-renewal. By increasing the reaction time of 
atom transfer radical polymerization (ATRP), we modified the gel architecture of PMEDSAH 
without changing its chemical structure. Polymer characterization determined differences in gel 
architecture among UVO-grafted PMEDSAH and ATRP PMEDSAH substrates that point 
towards alterations in the balance of inter-molecule associations between polymer chains. These 
alterations further influenced the interfacial properties of the substrate and demonstrated a 
profound effect on the culture and expansion of hPSCs. While all four coatings were able to 
maintain hPSC self-renewal and pluripotency over long-term culture, the 105 nm thick ATRP 
PMEDSAH was found to perform significantly better than the other three substrates because of 
its optimal gel architecture for hPSC expansion with intermediate thickness, hydrophilicity, 
surface charge, and a moderate degree of inter-chain association. Our results demonstrated that 
the physical properties significantly influenced the ability of PMEDSAH to support hPSC 
expansion. The newly developed 105 nm thick ATRP PMEDSAH can be used as an effective 
substrate for scalable production of hPSCs for application in regenerative medicine. 
From the molecular biological perspective, the pluripotency of hPSCs is maintained by a 
network of transcription factors and signaling pathways [13]. The culture conditions that are 
appropriate for hPSC maintenance are ones that are able to support pluripotency via this network. 
Although a specific group of transcription factors such as OCT4, SOX2 and NANOG are known 
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to compose this core circuitry [14-18], this regulatory network is not well characterized because 
many other pluripotency-related factors and their function are still unknown. It is also unclear 
whether this regulatory network is impacted by different in vitro culture conditions. In this thesis, 
we compared the gene expression of hPSCs cultured on PMEDSAH and other substrates. 
Interestingly, we found that the gene expression of Developmental Pluripotency Associated 5 
(DPPA5), a pluripotency marker with unknown function in PSCs, was consistently higher on 
PMEDSAH and other feeder-free substrates compared to the most widely used hPSC culture 
condition, mouse embryonic fibroblasts (MEFs). We further determined the protein levels of 
DPPA5 in hPSCs cultured on different substrates and investigated the function of DPPA5 in 
hPSC pluripotency and reprogramming. 
Our results demonstrated that in vitro culture conditions influence the gene expression and 
protein levels of DPPA5 in hPSCs. The extracellular matrix (ECM) and soluble factors secreted 
by irradiated MEFs inhibit the expression of DPPA5 in hPSCs, while its expression and function 
is permissive under feeder-free conditions such as PMEDSAH. DPPA5 stabilizes protein levels 
and enhances the function of NANOG, a master transcription factor regulating hPSC 
pluripotency. Moreover, DPPA5 increases the reprogramming efficiency of somatic cells into 
hiPSCs when transduced with OCT4, SOX2, KLF4 and C-MYC reprogramming cocktail. Taken 
together, DPPA5 plays an important role in supporting hPSC self-renewal, pluripotency and 
reprogramming. Our findings provide novel molecular insight into the mechanism by which 
synthetic polymer PMEDSAH and other feeder-free substrates support hPSC self-renewal. The 
newly discovered function of the PSC marker DPPA5 in hPSCs not only advances our 
knowledge of stem cell biology, but also offers improvements to current protocols in hPSC 
maintenance and reprogramming. In addition, the protein and protein interaction and 
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stabilization of NANOG by DPPA5 suggest that in addition to the broadly investigated 
transcriptional regulation of pluripotency-related factors, post-translational regulation also plays 
a crucial role in the hPSC pluripotency regulatory network.  
In summary, we investigated the mechanism by which synthetic polymers support hPSC self-
renewal by determining the role of hydrogel physical properties and specific pluripotency-related 
factors in this process. We found that physical properties influence the ability of synthetic 
polymer coatings to support hPSC self-renewal. A specific range of hydrogel thickness may 
enhance the expansion of hPSCs on PMEDSAH. Modifying the gel architecture of PMEDSAH 
surface coating by increasing its thickness may advance our current techniques of hPSC 
expansion and maintenance. We also determined that DPPA5 functions in hPSCs to support 
hPSC self-renewal, pluripotency and reprogramming by regulating NANOG turnover. The 
expression and function of DPPA5 are permissive under feeder-free conditions including 
PMEDSAH, while MEF-extracellular matrix (ECM) and secreted soluble factors inhibit its 
expression in hPSCs, which suggests that the pluripotency regulatory network in hPSCs is 
influenced by in vitro culture conditions. The new insights of the function of DPPA5 in hPSCs 
extend our understanding of hPSCs biology and may further advance our current hPSC 
maintenance and reprogramming techniques. Our work builds a bridge from culture substrates, to 
molecular biology, to cell behavior, which truly merges the physical and life sciences. 
5.2 Prospectus 
5.2.1 Human Embryonic Stem Cells or Human Induced Pluripotent Stem Cells-Which 
Way to Go?   
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Because of the great potential in regenerative medicine, especially their specific advantages for 
research and clinical purposes, both hESCs and hiPSCs will continue to attract tremendous 
scientific interests. 
As the field progresses, the study of hPSCs, such as hESCs, will remain an important area of 
research because no other human cell-type has as much capacity to reveal insights into early 
events in human development. hESCs also represent normal human cells that have not undergone 
genetic manipulation and since hESCs can be derived from embryos with naturally occurring 
genetic mutations, the study of disease-specific ESCs should lead to improved diagnosis and 
treatment for specific inherited diseases. 
However, the study of hiPSCs, and the recent advances in direct cell reprogramming will likely 
surpass hESCs in the potential for regenerative medicine as methods are developed to safely and 
reproducibly generate personalized cells. Because of the epigenetic modifications of DNA that 
are inherent in genetic reprogramming may be influenced by the character of the parental cell 
type [19], iPSCs may turn out to be more easily directed to differentiate toward specific tissues 
that their parental cells are from. For example, hiPSCs generated from cells of dental origin may 
have a greater potential to regenerate many of the unique structures in the oral cavity. 
5.2.2 Future Directions of Physico-chemical Property Modifications of Synthetic Polymer 
Coatings for Human Pluripotent Stem Cell Propagation 
In this thesis, we successfully generated a novel experimental model to test the effect of hydrogel 
gel architecture on hPSC behavior, which suggests that physical properties of synthetic polymer 
coatings play an important role in hPSC expansion. In order to thoroughly understand the 
mechanism by which synthetic polymer coatings such as PMEDSAH support hPSC self-renewal, 
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we may also investigate the impact of other hydrogel physico-chemical properties on hPSC 
function. These investigations can be achieved by the following modifications of PMEDSAH 
structure: 1) replace the sulfonate group with a phosphonate group; 2) increase the distance 
between cationic and anionic groups; 3) change the linkage to the polymer backbone from ester 
to amide; 4) synthesize a head-end type variant (R2) (Figure 5-1). Similar to our current 
experimental model, cell adhesion, proliferation and self-renewal will be determined by the 
number and area of undifferentiated colonies, total cell number, stem cell marker expression and 
pluripotency of the hPSCs cultured on different modified PMEDSAH. By screening which 
physico-chemical properties of PMEDSAH may be critical for hPSC maintenance, we may 
further advance our knowledge and improve our current techniques in hPSC self-renewal and 
expansion. Based on these potential findings, it is very promising to establish a database of 
substrate physico-chemical properties that impact hPSC behavior, and allow new synthetic 
substrates to be designed and optimized with high efficiency. 
We found in this thesis that 105 nm thick ATRP PMEDSAH performs significantly better for 
hPSC expansion than the other substrates because of its optimal gel architecture for hPSC 
expansion. It would be interesting to determine whether this optimal gel architecture enhances 
the expression of molecules related to specific cell behaviors. Cell adhesion on different 
synthetic substrates is one example of this experimental question. Cell surface proteins such as 
E-cadherin, epithelial cell adhesion molecule (EpCAM), α-integrins 1-6 and v and β-integrin 
1 and 2 are known to mediate cell-matrix interactions [20] By comparing the expression profiles 
of these cell adhesion molecules in hPSCs on different substrates as well as the subsequent 
functional assays, we may determine which molecules function as the “link” through which 
polymer gel architecture regulates hPSC adhesion. These potentially determined molecules and 
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their involved signaling pathways may extend our understanding of how physical properties of 
synthetic substrates impact hPSC behavior and further fill in the hole in the currently missing 
part of our knowledge connecting material physics and hPSC biology.  
5.2.3 Further Consideration of the Role of DPPA5 in Pluripotency Regulatory Network and 
Reprogramming  
Our findings that DPPA5 interacts with and stabilizes NANOG protein provide new insights into 
the regulation of NANOG in hPSCs, suggesting that in addition to the broadly investigated 
transcriptional regulation of pluripotency-related factors, post-translational regulation also plays 
a role in the pluripotency regulatory network. Recent studies indicate that NANOG could be 
regulated by post-translational modifications such as ubiquitination or phosphorylation in hPSCs 
[21-23]. It will be interesting to identify if DPPA5 stabilizes NANOG by blocking ubiquitin-
dependent proteolysis or through phosphorylation. Through modifications of the potentially 
involved residues, we may further determine the binding sites of DPPA5 in NANOG proteins. 
These studies may provide a more profound understanding of the molecular mechanism that how 
DPPA5 regulates NANOG in hPSCs. 
A major concern for reprogramming is the oncogenic potential of reprogramming factors. C-
MYC and KLF4 are well known oncogenic proteins that are overexpressed in a broad range of 
human cancers and are often associated with poor prognoses [24, 25]. We found that the addition 
of DPPA5 to the reprogramming cocktail (OCT4, SOX2, KLF4 and C-MYC: OSKM) increased 
the generation of iPSCs greater than 3-fold when compared to the OSKM control group. The key 
role of NANOG in iPSC-reprogramming [26-29], combined with our finding that DPPA5 
regulates NANOG protein levels, suggests that DPPA5 may promote hiPSC-reprogramming 
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efficiency by enhancing NANOG and its function during the reprogramming process. Therefore, 
it would be very important to determine if DPPA5 is able to replace C-MYC or/and KLF4 for 
hiPSC-reprogramming. If true, this approach may decrease the risk of tumorigenicity of hiPSCs 
and their derivatives by our current reprogramming protocols and live up to its full potential for 
regenerative medicine. 
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5.3 Figures 
 
Figure 5-1. Future modifications of PMEDSAH structure The impact of hydrogel physico-
chemical properties on hPSC behaviors will be investigated by cell culture on PMEDSAH with 
the following modifications: 1. replace the sulfonate group with a phosphonate group; 2. increase 
the distance between cationic and anionic groups; 3. change the linkage to the polymer backbone 
from ester to amide; 4. synthesize a head-end type variant (R2). 
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